11,258 results on '"NLR, neutrophil-to-lymphocyte ratio"'
Search Results
2. [The predictive value of normal-range NLR (neutrophil-to-lymphocyte ratio) in SARS-CoV-2 infection during pregnancy].
- Author
-
Supák D, Turi B, Kovács BG, Ács N, Mészáros B, Kukor Z, and Valent S
- Subjects
- Humans, Female, Pregnancy, Retrospective Studies, Adult, SARS-CoV-2, Lymphocyte Count, Predictive Value of Tests, Leukocyte Count, COVID-19 blood, COVID-19 diagnosis, COVID-19 immunology, COVID-19 complications, Neutrophils, Pregnancy Complications, Infectious blood, Pregnancy Complications, Infectious diagnosis, Lymphocytes
- Published
- 2024
- Full Text
- View/download PDF
3. 11476 Association of Pre-Operative NLR (Neutrophil-to-Lymphocyte Ratio) With Disease Severity in Surgically Managed Endometriosis.
- Author
-
Massad, NL, Wood, M, Day, M, Waters, CH, Patsia, R, Blaber, J, Kim, S, and Lian, X
- Abstract
To determine whether pre-operative neutrophil-to-lymphocyte ratio (NLR) correlates with endometriosis severity in patients with pathology-confirmed endometriosis surgically staged by MIGS providers at our institution using the 2021 American Association of Gynecologic Laparoscopists (AAGL) endometriosis classification system. Retrospective chart review of all patients who underwent primary surgery for endometriosis between January 2018 and December 2023 at Stony Brook University Hospital with pathology-confirmed endometriosis. Large academic medical center in Long Island, New York. All patients who underwent primary surgery for endometriosis in the study time period with pathology-confirmed endometriosis. Patients with comorbidities or medication use that affect systemic inflammation (i.e. malignancy, active infection, autoimmune and hematological disorders) were excluded from the study. Demographic data, clinical history, and pre-operative bloodwork were retrospectively recorded. Using operative findings and pathology reports, all patients were staged according to the 2021 AAGL endometriosis classification system. Thus far, we have collected data and performed statistical analysis on 77 patients who met inclusion criteria. Our preliminary analysis of variance and Mood's median tests find statistically significant differences in NLR across stages 1 through 3 (p<0.05). Our preliminary data suggest that pre-operative NLR correlates positively with surgical stage of endometriosis. Therefore, NLR may be a useful prognostic marker in endometriosis and may aid in predicting surgical complexity pre-operatively. Data collection is ongoing in order to reach statistical power. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. The uses of platelet indices, NLR (Neutrophil to Lymphocyte Ratio) and PLR (Platelet to Lymphocyte Ratio) in the predictive value diagnosis of benign and malignant masses of the parotid gland.
- Author
-
Aslan, Mehmet and Tan, Mehmet
- Subjects
- *
NECK surgery , *CYTOLOGY , *SALIVARY gland cancer , *LYMPHOCYTES ,PAROTID gland tumors - Abstract
Aim: Parotid gland tumors are uncommon in the head and neck surgery practice and difficult to surgically treat. Planning is very important, especially while planning parotid gland surgery, considering the difficulty of revision surgery. In this context, fine-needle aspiration cytology and radiological imaging stand out. However, preoperative diagnosis is sometimes difficult due to the nature of the salivary gland. At this point, additional methods in preoperative diagnosis are questioned. In our study, it was aimed to determine the surgical modality based on the predictive value in parotid benign and malignant masses with inexpensive, fast and easily obtainable platelet indices, NLR (Neutrophil to Lymphocyte Ratio) and PLR (Platelet to Lymphocyte Ratio). Materials and Methods: The data of 236 patients who were operated on with parotid masses between 2010 and 2020 in our clinic were retrospectively analyzed. The data of the patients and the control group were evaluated statistically. Results: A total of 356 participants were included in the study, including 236 patients who had undergone parotid gland surgery and a control group of 120 healthy individuals. When the data of the participants were reviewed, there was no significant difference between the groups in terms of age. In terms of sex, the number of the male patients was significantly higher than the female participants in the group with only parotid benign neoplasia. Based on the collected data, the mean MPV (Mean Platelet Volume) values were mean 9.1548 ± 1.55152 in the parotid cancer patient group (n1), 9.3810 ± 1.57825 in the inpatient group with parotid benign mass (n2) and 10.49250± 1.05314 in the control group (n3). The mean NLR values were found as 3.6395 ± 3.36035 in the parotid cancer patients (n1), 2.0145 ± 1.04293 in the parotid benign masses (n2) and 1.9689 ± 1.54979 in the control group (n3). The mean PDW (Platelet Distribution Width) values were found as 14.1258 ± 2.82536 in the parotid cancer patient group (n1), 14.5220 ± 2.69823 in the parotid benign mass group (n2), and 12.5150 ± 2.49953 in the control group (n3). Conclusion: In our study, we observed that the MPV, PDW and NLR values were significantly changed in the parotid gland tumors. We concluded that NLR values may be used effectively, especially in the predictive diagnosis of malignant masses and in planning surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. A normáltartományban maradó NLR (neutrophil-lymphocyta arány) prediktív értéke a várandósság alatt jelentkező SARS-CoV-2-fertőzésben.
- Author
-
Supák, Dorina, Turi, Balázs, Kovács, Bence Géza, Ács, Nándor, Mészáros, Balázs, Kukor, Zoltán, and Valent, Sándor
- Abstract
Copyright of Hungarian Medical Journal / Orvosi Hetilap is the property of Akademiai Kiado and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
6. Predictive diagnostic value of mean platelet volume to platelet count and neutrophil to lymphocyte ratios in the gray zone of prostate cancer with tPSA between 4 to 10 ng/mL
- Author
-
Xinyu Yi, Jin Li, Yilin Li, Tao Huang, Baiyi Xiong, Feng Zhang, and Zhaoyi Zhao
- Subjects
PVI ,NLR (neutrophil-to-lymphocyte ratio) ,prostate cancer ,tPSA gray zone ,predictive ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
ObjectiveExploration of the Predictive Diagnostic Value of Mean Platelet Volume to Platelet Count Ratio (MPV/PLT,PVI) and Neutrophil-to-Lymphocyte Ratio (NLR) in the tPSA Gray Zone of Prostate CancerMethodsA retrospective study was conducted on 65 prostate cancer (Pca) patients and 52 benign prostatic hyperplasia (BPH) patients who underwent transperineal prostate biopsy at Xiangtan Central Hospital from December 2021 to December 2023. Descriptive statistics and logistic regression models were used to investigate the predictive diagnostic value of PVI and NLR in the tPSA gray zone of prostate cancer. Receiver operating characteristic (ROC) curves were constructed based on PVI and NLR values to determine the classification thresholds.ResultsA total of 117 patients were enrolled, including 65 cases of prostate cancer (PCa) and 52 cases of benign prostatic hyperplasia (BPH). There were no statistically significant differences in age, BMI, history of hypertension, history of diabetes, history of coronary heart disease, pre-biopsy white blood cell count, history of drinking, history of smoking, and tPSA between the PCa and BPH patients. The results of logistic regression analysis showed that PVI (OR=2.03, 95%CI: 1.34~3.07, P
- Published
- 2024
- Full Text
- View/download PDF
7. A Prospective Study on the Roles of the Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer
- Author
-
Cieszymierz Gawiński, Andrzej Mróz, Katarzyna Roszkowska-Purska, Iwona Sosnowska, Edyta Derezińska-Wołek, Wojciech Michalski, and Lucjan Wyrwicz
- Subjects
LMR (lymphocyte-to-monocyte ratio) ,NLR (neutrophil-to-lymphocyte ratio) ,PLR (platelet-to-lymphocyte ratio) ,inflammatory infiltrate ,CPS (combined positive score) ,rectal cancer ,Biology (General) ,QH301-705.5 - Abstract
Rectal cancer constitutes over one-third of all colorectal cancers (CRCs) and is one of the leading causes of cancer-related deaths in developed countries. In order to identify high-risk patients and better adjust therapies, new markers are needed. Systemic inflammatory response (SIR) markers such as LMR, NLR, and PLR have proven to be highly prognostic in many malignancies, including CRC; however, their roles in locally advanced rectal cancer (LARC) are conflicting and lack proper validation. Sixty well-selected patients with LARC treated at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, between August 2017 and December 2020 were prospectively enrolled in this study. The reproducibility of the pre-treatment levels of the SIR markers, their correlations with clinicopathological characteristics, and their prognostic value were evaluated. There was a significant positive correlation between LMR and cancer-related inflammatory infiltrate (r = 0.38, p = 0.044) and PD-L1 expression in tumor cells, lymphocytes, and macrophages (combined positive score (CPS)) (r = 0.45, p = 0.016). The PLR level was correlated with nodal involvement (p = 0.033). The SIR markers proved to be only moderately reproducible and had no significant prognostic value. In conclusion, the LMR was associated with local cancer-related inflammation and PD-L1 expression in tumor microenvironments. The validity of SIR indices as biomarkers in LARC requires further investigation.
- Published
- 2023
- Full Text
- View/download PDF
8. The Relationship between Mean Platelet Volume and Neutrophil–Lymphocyte Ratio and Liver Fibrosis in Patients with Chronic Hepatitis B
- Author
-
Mehmet Onder Ekmen and Metin Uzman
- Subjects
chronic hepatitis B ,liver fibrosis ,MPV (mean platelet volume) ,NLR (neutrophil to lymphocyte ratio) ,Medicine (General) ,R5-920 - Abstract
Objective: The neutrophil–lymphocyte ratio (NLR) can be helpful both in demonstrating acute and chronic liver injury and predicting malignant potential. The mean platelet volume (MPV) is also a marker that can be used as a risk indicator in atherosclerosis-associated diseases, reflecting inflammation. Within the scope of this research, we aimed to elucidate the relationship between the mean platelet volume and neutrophil–lymphocyte ratio in liver fibrosis in chronic hepatitis B patients. Materials and Methods: A total of 84 patients who were followed up with the diagnosis of chronic hepatitis B and who underwent liver biopsy were included in this prospective study. Complete blood count parameters (neutrophil, lymphocyte, neutrophil–lymphocyte ratio, hemoglobin, thrombocyte, MCV, and MPV values), demographic data, biochemistry panel (AST, ALT), HBV DNA, and liver biopsy fibrosis scores obtained from hospital database were analyzed. Since the follow-up period of chronic hepatitis B patients is six months, patients were screened in order to include a full 3-year screening pool. Results: A total of 84 patients were enrolled within the scope of this study. The chronicity index was ‘0’ in 7.1% (n = 6), ‘1’ in 23.8% (n = 20), ‘2′ in 56% (n = 47), and ‘3’ in 13.1% (n = 11)of the patients. According to the chronicity index groups, there was a statistically significant difference between the medians of the hepatitis activity index (HAI) values at the 5% significance level (p < 0.001). The correlation analysis revealed a statistically significant relationship between the chronicity index and the mean platelet volume to lymphocyte ratio (MPVL). However, considering the degree of the relationship, it can be said that it was a positive and weak relationship (p = 0.046, r = 0.218). Conclusions: Regarding the outcomes of this research, a significant relationship was found between the neutrophil–lymphocyte ratio, mean platelet volume, and fibrosis.
- Published
- 2023
- Full Text
- View/download PDF
9. Clinical laboratory features of Meigs’ syndrome: a retrospective study from 2009 to 2018
- Author
-
Shang, Wenwen, Wu, Lei, Xu, Rui, Chen, Xian, Yao, Shasha, Huang, Peijun, and Wang, Fang
- Published
- 2021
- Full Text
- View/download PDF
10. Correlation of NLR with Oxidative Stress Markers in Sickle Cell Anemia with Vasoocclusive Crisis
- Author
-
Dash, Satarupa, Thakur, Atanu Kumar, and Bhoi, Sumitra
- Published
- 2019
- Full Text
- View/download PDF
11. Neutrophil–lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study
- Author
-
Zhang Y, Zou P, Gao H, Yang M, Yi P, Gan J, Shen Y, Wang W, Zhang W, Li J, Liu P, and Li L
- Subjects
NLR (neutrophil-to-lymphocyte ratio) ,influenza A ,AIV-H7N9 ,biomarker. ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Yan Zhang,1 Pengfei Zou,2 Hainv Gao,2 Meifang Yang,1 Ping Yi,1 Jianhe Gan,3 Yinzhong Shen,4 Weihong Wang,5 Wenhong Zhang,6 Jun Li,7 Peng Liu,8 Lanjuan Li11The State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China; 2Department of Infectious Disease, Shulan Hospital, Hangzhou, Zhejiang Province, People’s Republic of China; 3Department of Infectious Disease, The First Affiliated Hospital, Medical College of Soochow University, Suzhou, Jiangsu Province, People’s Republic of China; 4Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China; 5Department of Infectious Disease, Central Hospital of Huzhou, Zhejiang, People’s Republic of China; 6Department of Infectious Disease, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 7Department of Infectious Disease, Jiangsu Province People’s Hospital, Jiangsu, People’s Republic of China; 8Department of Infectious Disease, Ningbo No.2 Hospital, Ningbo, Zhejiang Province, People’s Republic of ChinaBackground: Avian AIV-H7N9 influenza progresses rapidly and has a high fatality rate. However, it lacks an early effective biomarker to predict disease severity and fatal outcomes successfully. Our study aimed to explore whether the neutrophil-to-lymphocyte ratio (NLR) taken within 24 h after admission can predict disease severity and fatality in AIV-H7N9-infected patients.Methods: We retrospectively studied 237 AIV-H7N9-infected patients from multiple centers from 2013 to 2015. We used univariate analysis and multivariate analysis to compare clinical variables between the survival and fatal groups to evaluate the prognostic value.Results: The NLR taken within 24 h after admission in the fatal group was significantly higher than that in the survival group (P
- Published
- 2019
12. Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer
- Author
-
Hiromichi Nakajima, Kenichi Harano, Tokiko Nakai, Shota Kusuhara, Takehiro Nakao, Chikako Funasaka, Chihiro Kondoh, Nobuaki Matsubara, Yoichi Naito, Ako Hosono, Shuichi Mitsunaga, Genichiro Ishii, and Toru Mukohara
- Subjects
NA, not available ,Immunoconjugates ,PD, progressive disease ,IHC, immunohistochemical score ,Receptor, ErbB-2 ,hetero, heterogenous ,NLR, neutrophil-to-lymphocyte ratio ,Breast Neoplasms ,MT, mutant-type ,PR, partial response ,PLR, platelet-to-lymphocyte ratio ,Humans ,homo, homogenous ,Maytansine ,Trastuzumab deruxtecan ,amp, amplification ,HER2-Positive metastatic breast cancer ,skin and connective tissue diseases ,RC254-282 ,Retrospective Studies ,Ado-trastuzumab emtansine ,SD, stable disease ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Biomarker ,General Medicine ,Trastuzumab ,n, number ,WT, wild-type ,PFS, progression-free survival ,Camptothecin ,Female ,Original Article ,IDC, invasive ductal carcinoma ,Surgery - Abstract
Background The previous second-line treatment for HER2-positive metastatic breast cancer were ado-trastuzumab emtansine (T-DM1); however, its activity is decreased in tumors with heterogenous, reduced, or loss of HER2 expression. Trastuzumab deruxtecan (T-DXd) has recently been developed as a novel antibody-drug conjugate to overcome resistance to T-DM1. However, clinical evidence on its ability to overcome this resistance is limited. Materials and methods We retrospectively analyzed data for patients with HER2-positive metastatic breast cancer who received T-DXd at our institution from April 2020 to March 2021. We evaluated the associations between clinicopathological and molecular biomarkers and the efficacy of T-DXd. Results Twenty-two patients were enrolled in this study. The median progression-free survival (PFS) was 9.7 months (95% confidence interval [CI], 7.0–not reached [NR]), and the objective response rate (ORR) was 61.9%. The ORR and PFS were comparable between patients with HER2 immunohistochemistry scores of 3+ and 2+/1+ at initial diagnosis (ORR: 50.0% vs. 72.7%, p = 0.39; median PFS, 9.7 months [95%CI, 2.6–NR] vs. 8.3 months [95%CI, 7.1–NR]; hazard ratio, 1.86 [95%CI, 0.53–6.57], p = 0.34). Two patients with heterogenous HER2 expression had a partial response or long stable disease (≥6 months). Three of four patients with re-biopsy samples after anti-HER2 targeted therapy and with latest HER2 immunohistochemistry scores of 1+ experienced partial responses (75.0%) to T-DXd, but none had responded to prior T-DM1. Conclusions T-DXd demonstrated favorable activity in clinical practice. Moreover, T-DXd showed meaningful benefit in patients with heterogeneity, reduction, or loss of HER2 expression., Highlights • T-DXd showed favorable clinical activity against HER2-positive metastatic breast cancer. • T-DXd showed benefit in patients with heterogeneity, reduction, or loss of HER2 expression. • Patients with liver metastasis tended to have worse outcomes.
- Published
- 2022
- Full Text
- View/download PDF
13. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses
- Author
-
Nadereh, Naderi and Mahsa, Rahimzadeh
- Subjects
Adult ,Male ,ESR, erythrocyte sedimentation rate ,COVID-19, Coronavirus disease 2019 ,ILD, interstitial lung diseases ,CK, creatin kinase ,SARS-CoV-2 ,KL-6 ,Mucin-1 ,COVID-19 ,macromolecular substances ,Middle Aged ,Prognosis ,Severity of Illness Index ,Article ,KL-6, Krebs von den Lungen-6 ,IL, interleukin ,Virology ,CRP, C-reactive protein ,Humans ,Female ,Biomarkers ,NLR, neutrophil to lymphocyte ratio ,Aged - Abstract
Background Krebs von den Lungen-6 (KL-6) is a molecule that is predominantly expressed by damaged alveolar type II cells, and has been proposed as a marker of COVID-19 and the severity of the disease. Here, we performed a meta-analysis to determine whether KL-6 could be used as a prognostic factor for severe COVID-19. Methods PubMed, Cochrane and Google Scholar were searched until April 20, 2021, and 7 studies were included. KL-6 was considered as the outcome and pooled in meta-analyses. Results All included studies compared KL-6 in severe and non-severe patients. Serum KL-6 was higher in severe COVID-19 patients compared to non-severe (n = 6; SMD = 1.25; 95% CI: 0.99–1.5; P
- Published
- 2022
- Full Text
- View/download PDF
14. Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients (PERCEPTION)
- Published
- 2024
15. Hypnosis Sedation Used in Breast Oncologic Surgery Significantly Decreases Perioperative Inflammatory Reaction.
- Author
-
Berliere, Martine, Roelants, Fabienne, Duhoux, François P., Gerday, Amandine, Piette, Nathan, Lacroix, Camille, Docquier, Marie-Agnes, Samartzi, Vasiliki, Coyette, Maude, Hammer, Jennifer, Touil, Nassim, Azzouzi, Houda, Piette, Philippe, and Watremez, Christine
- Subjects
- *
INFLAMMATION prevention , *PAIN measurement , *NEUTROPHIL lymphocyte ratio , *NONSTEROIDAL anti-inflammatory agents , *ACADEMIC medical centers , *PSYCHOLOGICAL distress , *RESEARCH funding , *BREAST tumors , *POSTOPERATIVE pain , *CANCER patients , *ANXIETY , *LONGITUDINAL method , *EXPERIMENTAL design , *HYPNOTISM in surgery , *C-reactive protein - Abstract
Simple Summary: Hypnosis sedation has been used for anesthesia in breast oncologic surgery. This manuscript reports the results of a multicentric, prospective non-randomized study evaluating three different modalities of anesthesia for breast cancer surgery: general anesthesia, general anesthesia preceded by virtual reality with a hypnorelaxation session and hypnosis sedation exclusively in place of general anesthesia. Local anesthesia was systematically administered in all patients. Some benefits of hypnosis sedation, a decrease in pain and the consumption of non-steroidal anti-inflammatory drugs are correlated with a significant reduction in the inflammatory reaction in the perioperative process. Background: Hypnosis sedation has recently been used for anesthesia in breast oncologic surgery. Methods: Between January 2017 and October 2019, 284 patients from our Breast Clinic (Cliniques Universitaires Saint-Luc, Université Catholique de Louvain) and from the Jolimont Hospital were prospectively included in an interventional non-randomized study approved by our two local ethics committees and registered on clinicaltrials.gov (NCT03330117). Ninety-three consecutive patients underwent surgery while on general anesthesia (GA group). Ninety-two consecutive patients underwent surgery while on general anesthesia preceded by a hypnorelaxation session (GAVRH group). Ninety-five consecutive patients underwent surgery while exclusively on hypnosis sedation (HYPS group). Clinical parameters (pain score, anxiety and distress score) were measured on days 0, 1 and 8 for all patients. All evaluable patients underwent NLR (neutrophil-to-lymphocyte ratio) and CRP (C-reactive protein) dosage on days 0, 1 and 8. Results: Pain scores and anxiety scores were statistically lower in the HYPS group on days 1 and 8, as was the duration of NSAID consumption. NLR and CRP values were significantly inferior on day 1 for all patients who benefited from hypnosis sedation. Conclusions: Some benefits of hypnosis sedation (reduction in postoperative pain, decrease in NSAID consumption) are correlated with a significant reduction in inflammatory parameters in the perioperative process. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF
16. Clinical Features of 50 Cases of Chlamydia psittaci Pneumonia Identified Through Metagenomic Next-Generation Sequencing.
- Author
-
Chen, Jiamei, Wang, Jin, Deng, Ziwei, Li, Yongzhong, Liu, Yuni, and Zhou, Jianliang
- Subjects
LEUKOCYTE count ,LEUKOCYTES ,COMPUTED tomography ,NEUTROPHIL lymphocyte ratio ,NUCLEOTIDE sequencing ,COUGH - Abstract
Objective was to analyze the clinical and imaging features of Chlamydia psittaci pneumonia to enhance its diagnostic accuracy. Methods: We systematically reviewed the cases of Chlamydia psittaci diagnosed by next-generation sequencing at the Hunan University of Medicine General Hospital between March 2019 and June 2024, summarizing and analyzing their clinical characteristics and imaging features. Results: A total of 50 cases that met the inclusion criteria were ultimately included in the study analysis. The median age of the patients was 62.96± 11.08 years. Notably, 46 patients (92%) had potential exposure to birds or poultry. Forty-six patients (92%) temperature ≥ 39.0 °C, 37 patients (74%) had cough, 34 patients (68%) had moist rale, and 39 patients (78%) had a relatively slow pulse. Laboratory tests indicated that over 70% of patients exhibited elevated infection markers, accompanied by abnormalities in liver and renal function, electrolyte levels, and cardiac enzymes. Meanwhile, the patient's white blood cell count was normal. Chest CT (Computed Tomography) frequently revealed flaky shadows (94%), thoracic effusions (68%), and thickened pleura (54%). Bronchoscopy revealed significant bronchial mucosal hyperemia, swelling (93.478%), and reduced secretion (56.522%). A total of 44 patients (88%) showed a gradual improvement over 12 days. Forty patients (80%) were treated with doxycycline. Fifty patients were classified into two groups according to whether severe pneumonia occurred after admission. WBC (white blood cell), N% (percentage of neutrophils), NLR (Neutrophil-to-lymphocyte ratio), PLR (platelet/lymphocyte ratio), SII (platelet*Neutrophil/lymphocyte ratio), and PCT (procalcitonin) are indicators that suggest severe cases. Conclusion: The combination of the following indicators is expected to aid in diagnosis of Chlamydia psittaci pneumonia: opportunities to come into contact with birds or poultry, high fever, relatively slow pulse, and elevated infection indicators accompanied by organ injury. Treatment with doxycycline was effective and resulted in favorable prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. The Relationship between Inflammatory Markers and Activity of Multiple Sclerosis.
- Author
-
Ismail, Mohamed Hamdy, Al-Ma'mon Sarhan, Abd Allah, Abd El-Wahed, Zahraa Mahmoud, and elDeen, Engy Emad
- Subjects
PLATELET lymphocyte ratio ,MAGNETIC resonance imaging ,DISABILITIES ,AUTOIMMUNE diseases ,NEUTROPHIL lymphocyte ratio - Abstract
Copyright of Zagazig University Medical Journal is the property of Association of Arab Universities and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
18. Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study
- Author
-
Heita Kitajima, Hiroshi Morishita, Tomoki Yamada, Seijiro Minamoto, Tsuyoshi Arai, Tohru Takeshita, Kayoko Kawashima, Seiji Yamaguchi, Yozo Kashiwa, Takayuki Nagai, Makoto Kameda, Tomonori Hirashima, Toshio Tanaka, Shoji Hashimoto, Hidekazu Suzuki, Yoshitaka Tamura, and Hiroto Matsuoka
- Subjects
Male ,s-Alb, serum albumin ,0301 basic medicine ,BUN, blood urea nitrogen ,Neutrophils ,BMI, body mass index ,AST, aspartate aminotransferase ,Disease ,Single Center ,Severity of Illness Index ,chemistry.chemical_compound ,PCR, polymerase chain reaction ,NIH, National Institutes of Health ,0302 clinical medicine ,Japan ,Risk Factors ,Pharmacology (medical) ,030212 general & internal medicine ,Young adult ,Lung ,CPR, C-reactive protein ,Illness severity ,Body mass index ,Aged, 80 and over ,LDH, lactate dehydrogenase ,RBS, random blood sugar ,IHDMPPT, intravenous high-dose methylprednisolone pulse therapy ,Age Factors ,MV, mechanical ventilation ,Middle Aged ,Tocilizumab ,CT, computed tomography ,IL-6, interleukin 6 ,C-Reactive Protein ,Infectious Diseases ,Female ,Original Article ,Coronavirus Infections ,Adult ,Microbiology (medical) ,medicine.medical_specialty ,Pneumonia, Viral ,NLR, neutrophil-to-lymphocyte ratio ,030106 microbiology ,macromolecular substances ,Antibodies, Monoclonal, Humanized ,LAMP, loop-mediated isothermal amplification ,Antiviral Agents ,Methylprednisolone ,SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 ,WHO, World Health Organization ,Betacoronavirus ,Young Adult ,03 medical and health sciences ,ALT, alanine aminotransferase ,MMI, moderate or mild illness ,Internal medicine ,Diabetes mellitus ,Severity of illness ,medicine ,Humans ,Pandemics ,Serum Albumin ,ARDS, acute respiratory distress syndrome ,Aged ,Retrospective Studies ,Systemic inflammation ,SARS-CoV-2 ,business.industry ,COVID-19 ,Retrospective cohort study ,CSI, severe critical illness ,medicine.disease ,Respiration, Artificial ,CRN, creatinine ,chemistry ,Tomography, X-Ray Computed ,business ,GCT, glucocorticoid therapy - Abstract
Introduction The severity of coronavirus disease (COVID-19) in Japanese patients is unreported. We retrospectively examined significant factors associated with disease severity in symptomatic COVID-19 patients (COVID-Pts) admitted to our institution between February 20 and April 30, 2020. Methods All patients were diagnosed based on the genetic detection of severe acute respiratory syndrome coronavirus 2. Information on the initial symptoms, laboratory data, and computed tomography (CT) images at hospitalization were collected from the patients’ records. COVID-Pts were categorized as those with critical or severe illness (Pts-CSI) or those with moderate or mild illness (Pt-MMI). All statistical analyses were performed using R software. Results Data from 61 patients (16 Pt–CSI, 45 Pt-MMI), including 58 Japanese and three East Asians, were analyzed. Pt–CSI were significantly older and had hypertension or diabetes than Pt-MMI (P
- Published
- 2021
- Full Text
- View/download PDF
19. Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting
- Author
-
Melissa Y.Y. Moey, Cynthia R. Cherry, Paul R. Walker, Blase A. Carabello, Abdul Rafeh Naqash, Anna N. Tomdio, Justin D. McCallen, Lauren Vaughan, and Kevin O'Brien
- Subjects
lcsh:Diseases of the circulatory (Cardiovascular) system ,Myocarditis ,MACE, major adverse cardiac events ,ICI, immune checkpoint inhibitor ,Immune checkpoint inhibitors ,NLR, neutrophil-to-lymphocyte ratio ,Population ,iRC, immune checkpoint inhibitor-related cardiotoxicity ,lcsh:RC254-282 ,immune checkpoint inhibitors ,CTLA-4, cytotoxicity T-cell lymphocyte antigen ,neutrophil-to-lymphocyte ratio ,NSCLC, non-small cell lung cancer ,Medicine ,irAE, immune-related adverse events ,cardiovascular diseases ,Neutrophil to lymphocyte ratio ,education ,Lung cancer ,CTCAE, common terminology for clinical adverse events ,Original Research ,education.field_of_study ,Cardiotoxicity ,business.industry ,fungi ,Rural setting ,food and beverages ,Cancer ,PD, programmed cell death ,inflammatory markers ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,PD-L1, programmed cell death-ligand 1 ,Oncology ,lcsh:RC666-701 ,Cancer research ,myocarditis ,Cardiology and Cardiovascular Medicine ,business ,CAR T, chimeric antigen receptor T cell - Abstract
Background Immune checkpoint inhibitor (ICI)-related cardiotoxicity (iRC) is uncommon but can be fatal. There have been few reports of iRC from a rural cancer population and few data for iRC and inflammatory biomarkers. Objectives The purpose of this study was to characterize major adverse cardiac events (MACE) in ICI-treated lung cancer patients based in a rural setting and to assess the utility of C-reactive protein (CRP) and neutrophil-lymphocyte ratio (NLR) in the diagnosis of iRC. Methods Patients with lung cancer treated with ICIs at Vidant Medical Center/East Carolina University (VMC/ECU) between 2015 and 2018 were retrospectively identified. MACE included myocarditis, non-ST-segment elevated myocardial infarction (NSTEMI), supraventricular tachycardia (SVT), and pericardial disorders. Medical history, laboratory values, pre-ICI electrocardiography (ECG), and echocardiography results were compared in patients with and without MACE. Results Among 196 ICI-treated patients, 23 patients (11%) developed MACE at a median of 46 days from the first ICI infusion (interquartile range [IQR]: 17 to 83 days). Patients who developed MACE experienced myocarditis (n = 9), NSTEMI (n = 3), SVT (n = 7), and pericardial disorders (n = 4). Ejection fraction was not significantly different at the time of MACE compared to that at baseline (p = 0.495). Compared to baseline values, NLR (10.9 ± 8.3 vs. 20.7 ± 4.2, respectively; p = 0.032) and CRP (42.1 ± 10.1 mg/l vs. 109.9 ± 15.6 mg/l, respectively; p = 0.010) were significantly elevated at the time of MACE. Conclusions NLR and CRP were significantly elevated at the time of MACE compared to baseline values in ICI-treated patients. Larger datasets are needed to validate these findings and identify predictors of MACE that can be used in the diagnosis and management of ICI-related iRC., Central Illustration
- Published
- 2020
- Full Text
- View/download PDF
20. Neurosurgery Services in Dr. Sardjito General Hospital, Yogyakarta, Indonesia, During the COVID-19 Pandemic: Experience from a Developing Country
- Author
-
Endro Basuki, Rachmat Andi Hartanto, Wiryawan Manusubroto, Handoyo Pramusinto, Paulus Sudiharto, Daniel Agriva Tamba, and Adiguno Suryo Wicaksono
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,LMIC, Low- and middle-income countries ,Clinical Neurology ,Developing country ,COVID-19, Corona Virus Disease 2019 ,i.e., id est ,Article ,WHO, World Health Organization ,Dr., Doctor ,N95, Negativity at Approximately 95 Milliseconds (type of mask) ,LMIC ,03 medical and health sciences ,0302 clinical medicine ,Pandemic ,medicine ,BSL-2, Bio-Safety Level ,PPE, Personal protective equipment ,CT-scan, Computed tomography scan ,business.industry ,pandemic ,Online database ,COVID-19 ,medicine.disease ,RT-PCR, Reverse Transcription Polymerase Chain Reaction ,language.human_language ,Indonesian ,SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2 ,NLR, Neutrophil-to-lymphocyte ratio ,030220 oncology & carcinogenesis ,Local government ,CRP, C-reactive protein ,language ,neurosurgery service ,Surgery ,Neurology (clinical) ,Medical emergency ,Neurosurgery ,business ,Developed country ,030217 neurology & neurosurgery - Abstract
Background Most articles describing the effect of the coronavirus disease 2019 (COVID-19) pandemic on neurosurgical services have been from developed countries. We report our experience in carrying out neurosurgical services at Dr. Sardjito General Hospital, Yogyakarta, Indonesia, during the time of the pandemic. Methods To collect information on the effect of the pandemic in Indonesia and Yogyakarta, we gathered data from the Indonesian Ministry of Health's online database for the national data and local government records for the local data (including records of Dr. Sardjito General Hospital Division of Neurosurgery). Results Compared with other countries, Indonesia has not been severely hit by the impact of COVID-19. To increase our understanding of the natural history of the pandemic, we divided the period into 4 phases: phase 1 (when there were confirmed cases in Indonesia but no cases in Yogyakarta), phase 2 (when the first case in Yogyakarta was detected), phase 3 (when the cumulative cases surpass their peak), and phase 4 (when the pandemic ends). At the time of this writing, we were still in phase 2 and in this phase, we experienced a decrease in the number of emergency surgical procedures, from an average of 4 to 2.4 per week. Moreover, the number of elective operations dropped from an average of 12 to 9 per week. Conclusions A pandemic, such as COVID-19, reduces both inpatient and outpatient neurosurgical activities. A comprehensive plan can improve both utilization and safety of the neurosurgical staff.
- Published
- 2020
- Full Text
- View/download PDF
21. Association between inflammation‐related indicators and vertebral fracture in older adults in the United States: A cross‐sectional study based on National Health and Nutrition Examination Survey 2013–2014.
- Author
-
Gou, Yuwei, Xie, Xiansong, Yin, Heng, Wu, Yucheng, Wen, Yongjie, and Zhang, Yingbo
- Subjects
VERTEBRAL fractures ,NATIONAL Health & Nutrition Examination Survey ,RECEIVER operating characteristic curves ,PLATELET count ,OLDER people ,VERTEBRAE injuries - Abstract
Objective: This study was to examine the association between inflammation‐related indexes SII (systemic immune‐inflammation index), NLR (neutrophil‐to‐lymphocyte ratio), PPN (product of platelet count and neutrophil count), and PLR (platelet‐to‐lymphocyte ratio), and the occurrence of vertebral fractures in older Americans. Methods: Patients ⩾60 years of age from the 2013–2014 NHANES database were selected for this study. Restricted cubic spline models and weighted logistic regression models were used to assess the association between inflammation‐related indexes and the occurrence of vertebral fractures in older Americans. The predictive value of the inflammation‐related indexes on the occurrence of vertebral fractures was assessed using receiver operating characteristic curves (ROC). To examine the robustness of the main findings, a sensitivity analysis was conducted. Results: A total of 1281 patients were included in the analysis, of whole 120 suffered vertebral fractures. Fully adjusted logistic regression showed a significant linear relationship between NLR and the occurrence of vertebral fracture in older Americans (p <.05), but no relationship was found between SII, PLR, and the occurrence of vertebral fracture in older Americans. Meanwhile, NLR was slightly better than other indicators in predicting vertebral fracture. Conclusions: This study found that NLR, as a novel inflammatory marker, can predict the risk of vertebral fracture in older Americans, which is of clinical significance for the prevention and treatment of vertebral fracture in older adults. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Neutrophil-to-lymphocyte ratio in type 2 diabetes patients combined with Lower Extremity Peripheral Artery Disease.
- Author
-
Li Li, Mengjie Wang, Ting Jia, Xiaowan Jiang, Fan Yang, Zhongjing Wang, and Xuyan Zhang
- Subjects
DIGITAL subtraction angiography ,RECEIVER operating characteristic curves ,HDL cholesterol ,PERIPHERAL vascular diseases ,LDL cholesterol ,GLYCOSYLATED hemoglobin - Abstract
Objective: This study explored the utility of NLR (neutrophil-to-lymphocyte ratio) as a marker to predict Lower Extremity Peripheral Artery Disease (PAD) in the Chinese population, as well as to assess its consistency and diagnostic value with digital subtraction angiography. Methods: Patients were distributed into three groups according to the angiography in lower limb arterial: group L1, plaque with no stenosis; group L2, plaque with luminal stenosis and group L3, total vascular occlusion. Changes in the neutrophil-to-lymphocyte ratio were documented and compared among groups. Results: Compared to group L1, NLR was significantly increased in L2 (1.76 vs 2.35, p=0.037) and L3 (1.76 vs 3.60, p<0.001), with a gradual decrease in ABI (Ankle-Brachial Index, 1.11 vs 1.02 vs 0.94, p<0.001). Those older patients with higher prevalence of hypertension (p=0.002), obesity (p=0.032), or reduced high-density lipoprotein cholesterol (p=0.020) were more likely to develop PAD; higher glycosylated hemoglobin (p=0.045), low-density lipoprotein cholesterol (p=0.006), and systolic blood pressure (p<0.001) levels led to a greater tendency to suffer stenosis or even occlusion; the probability of severe stenosis (>70%) increased to 2.075 times for every 1 increase in NLR, while it was 46.8% for every 0.1 increase in ABI. The optimal NLR cut-off value to predict severe stenosis in PAD was 2.73. Receiver operating characteristic curve analysis of the inflammatory biomarkers and severe stenosis prediction displayed an area under the curve of 0.81. Conclusion: NLR could serve as a new noninvasive and accurate marker in predicting PAD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Relationship between NLR and penile squamous cell carcinoma: a systematic review and meta-analysis.
- Author
-
Babadi, Saghar, Shahri, Matin Moallem, Nematollahi, Sima Foroughi, Barpujari, Arnav, Clark, Alec, Lucke-Wold, Brandon, Sarejloo, Shirin, Ghaedi, Arshin, Bazrgar, Aida, and Khanzadeh, Shokoufeh
- Subjects
NEUTROPHIL lymphocyte ratio ,SQUAMOUS cell carcinoma ,PROGRESSION-free survival ,PROGNOSIS ,TUMOR classification - Abstract
Objective: We conducted this study to summarize the results of studies reporting the role of NLR (neutrophil to lymphocyte ratio) in PSCC (penile squamous cell carcinoma). Methods: This meta-analysis was conducted using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria. A systematic search was conducted on PubMed, Scopus, and web of science up to March 10, 2023. Fourteen studies were included in the review. The NOS (Newcastle–Ottawa Scale) was used to determine the quality of the included studies. This meta-analysis was conducted on the studies reporting the relationship between NLR and survival using HR (hazard ratio) and 95% CI (confidence interval). Results: There was a significant association between NLR levels and the prognosis, nodal stage, and anatomical tumor stage of PSCC patients. In the meta-analysis of the association of NLR with survival, NLR level was significantly associated with lower cancer-specific survival (HR = 3.51, 95% CI = 2.07–5.98, p < 0.001) and lower disease-free survival (HR = 2.88, 95% CI = 1.60–5.20, p < 0.001). However, NLR was found to have no association with the stage, grade, location, and size of the tumor. Conclusion: NLR has a significant diagnostic and prognostic value in PSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. The potential indicators for pulmonary fibrosis in survivors of severe COVID-19
- Author
-
Shuixing Zhang, Zhuozhi Chen, Wenhui Huang, Jie Tian, Kun Wang, Qingxia Wu, and Zhiyuan Xiong
- Subjects
Microbiology (medical) ,COVID-19, Coronavirus disease 2019 ,LDH, Lactate dehydrogenase ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,TLC, total lung capacity ,NLR, Neutrophil to lymphocyte ratio ,medicine.disease ,DLCO, Diffusing Capacity of the lungs for carbon monoxide ,SARS-CoV, Severe acute respiratory syndrome coronavirus ,RT-PCR, Realtime Polymerase chain reaction ,ICU, Intensive care unit ,Infectious Diseases ,Pulmonary fibrosis ,Immunology ,CRP, C-reactive protein ,medicine ,CT, Computed tomography ,business ,Letter to the Editor ,IQR, interquartile range - Published
- 2021
- Full Text
- View/download PDF
25. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19
- Author
-
Jacob George, Kenneth I. Zheng, Christopher D. Byrne, Mohammed Eslam, Alessandro Mantovani, Qing-Feng Sun, Xiao Bo Wang, Hua-Dong Yan, Ming-Hua Zheng, Giovanni Targher, Yong-Ping Chen, and Ke-Hua Pan
- Subjects
2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Endocrinology, Diabetes and Metabolism ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,NLR, neutrophil-to-lymphocyte ratio ,MAFLD ,030209 endocrinology & metabolism ,Disease ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Article ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Internal Medicine ,MAFLD, metabolic dysfunction-associated fatty liver disease ,Medicine ,Neutrophil to lymphocyte ratio ,COVID-19, coronavirus disease 2019 ,Coronavirus ,Coronavirus disease 2019 ,business.industry ,Fatty liver ,COVID-19 ,General Medicine ,medicine.disease ,95% CI, 95% confidence intervals ,OR, odds ratio ,Metabolic associated fatty liver disease ,Immunology ,business - Abstract
Diabetes & Metabolism - Sous presse. Manuscrit accepte. Disponible en ligne depuis le jeudi 4 juin 2020
- Published
- 2020
- Full Text
- View/download PDF
26. Neutrophils: Homing in on the myeloid mechanisms of metastasis
- Author
-
Joshua D.G. Leach, Jennifer P. Morton, and Owen J. Sansom
- Subjects
0301 basic medicine ,Myeloid ,Neutrophils ,STAT3, signal transducer and activator of transcription 3 ,TAM, tumour-associated macrophages ,EMT, epithelial to mesenchymal transition ,CCR, C-C motif chemokine receptor ,ICAM, intercellular adhesion molecule ,APC, antigen presenting cell ,TNF, tumour necrosis factor ,Metastasis ,0302 clinical medicine ,NET, neutrophil extracellular trap ,Neoplasms ,FACS, fluorescence-activated cell sorting ,CXCL, C-X-C motif chemokine ligand ,Tumor Microenvironment ,Myeloid Cells ,TGFβ, transforming growth factor beta ,Neoplasm Metastasis ,Epithelial cancer ,PD1, programmed cell death protein 1 ,VEGF, vascular endothelial growth factor ,Extravasation ,ECM, extracellular matrix ,MET, mesenchymal-to-epithelial transition ,MMP, matrix metalloproteinase ,Chemotaxis, Leukocyte ,medicine.anatomical_structure ,GM-CSF, granulocyte-macrophage colony stimulating factor ,Disease Progression ,G-CSF, granulocyte-colony stimulating factor ,NF-κB, nuclear factor kappa B subunit 1 ,PI3K, phosphoinositide 3-kinase ,Cell type ,Stromal cell ,CCL, C-C motif chemokine ligand ,Immunology ,CXCR, C-X-C motif chemokine receptor ,TAN, tumour-associated neutrophils ,Biology ,Article ,NK, Natural Killer ,03 medical and health sciences ,ROS, reactive oxygen species ,Immune system ,medicine ,Animals ,Humans ,IFN, interferon ,TLR, toll-like receptor ,Molecular Biology ,gMDSCs, granulocytic myeloid-derived suppressor cells ,Tumour microenvironment ,HOCL, hypochlorous acid ,Intravasation ,SDF1, stromal cell-derived factor 1 ,medicine.disease ,iNOS, Inducible nitric oxide synthase ,FGF, fibroblast growth factor ,IL, interleukin ,030104 developmental biology ,Cancer research ,TIMP-1, tissue inhibitor of metalloprotease 1 ,MAPK, mitogen-activated protein kinase ,NLR, neutrophil to lymphocyte ratio ,030215 immunology ,Homing (hematopoietic) - Abstract
Highlights • Neutrophils play important roles throughout the metastatic process. • Tumour progression and invasion are influenced by infiltrating neutrophils. • Signalling from neutrophils can enhance survival of circulating tumour cells. • Neutrophils play a key role in establishing the metastatic niche., The metastasis cascade is complex and comprises several stages including local invasion into surrounding tissue, intravasation and survival of tumour cells in the circulation, and extravasation and colonisation of a distant site. It is increasingly clear that these processes are driven not only by signals within the tumour cells, but are also profoundly influenced by stromal cells and signals in the tumour microenvironment. Amongst the many cell types within the tumour microenvironment, immune cells such as lymphocytes, macrophages and neutrophils play a prominent role in tumour development and progression. Neutrophils, however, have only recently emerged as important players, particularly in metastasis. Here we review the current evidence suggesting a multi-faceted role for neutrophils in the metastatic cascade.
- Published
- 2019
- Full Text
- View/download PDF
27. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways
- Author
-
Zeinab Amini-Farsani, Mahtab Yadollahi-Farsani, Samira Asgharzade, Fatemeh Forouzanfar, Mitra Yadollahi, and Samaneh Arab
- Subjects
Disease ,TRAF5, Tumor necrosis factor receptor associated factor-5 ,TLRs, Toll-like receptors ,NF-kB, Nuclear factor kappa B ,MAPK, Mitogen‑activated protein kinase ,NK, Natural killer ,eMDSCs, early-stage myeloid-derived suppressor cells ,MIP1-α, Macrophage inflammatory protein 1-α ,TNF-α, Tumor necrosis factor alpha ,NF-kB ,TRAF2, Tumor necrosis factor receptor associated factor-2 ,CNS, Central nervous system ,NF-kappa B ,ERK, Extracellular signal-regulated kinase ,EGF, Epidermal growth factor ,CRP, C-reactive protein ,CD8, Cluster of differentiation 8 ,DEGs, Differentially expressed genes ,JAK, Janus kinase ,IP-10, interferon gamma-induced protein 10 ,SOCS3, Suppressor of cytokine signaling 3 ,Immunology ,MCP-1/CCL2, Monocyte chemotactic protein ,IP-10, Interferon IFN-γ inducible protein-10 ,IGF1R/PI3K, Insulin growth factor I receptor/phosphatidylinositol-3-kinase ,Article ,IgAN, Immunoglobulin a nephropathy ,CCR2, Chemokine receptor type 2 ,microRNA ,Humans ,GP130, Glycoprotein 130 ,EDAR, Ectodysplasin A receptor ,TNF‐β, Tumor necrosis factor-beta ,Janus Kinases ,Pharmacology ,SLE, Lupus erythematosus ,SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 ,PTEN, Phosphatase and tensin homolog ,FABP4, cells Fatty acid binding protein 4 ,PKC, protein kinase ,IFNs, Interferons ,IFNGR1, Interferon gamma receptor 1 ,TLR‐3, Toll-like receptor 3 ,IRFs, Interferon-regulatory factors ,MCPIP1, Monocyte chemotactic protein-1-induced protein-1 ,PBMCs, Peripheral blood mononuclear cells ,Bioinformatics ,NFKBIA, NFKB inhibitor alpha ,MCP-1, Monocyte chemoattractant protein-1 ,Immunology and Allergy ,PIAS3, protein inhibitor of activated STAT 3 ,CD4, Cluster of differentiation 4 ,RhoB, Ras homolog family member B ,RAS, Renin–angiotensin–system ,COVID-19, Coronavirus disease 2019 ,JAK-STAT signaling pathway ,ICAM1, Intercellular adhesion molecule 1 ,KD, Kawasaki disease ,RIPK1, Receptor-interacting protein kinase 1 ,PCT, Procalcitonin ,STAT Transcription Factors ,TRIM25, Tripartite motif containing 25 ,IL‐21, Interleukin-21 ,MIP-1A, Macrophage inflammatory protein-1α ,Signal transduction ,medicine.symptom ,ISGs, Interferon stimulated genes ,IL‐6, Interleukin-6 ,TRADD, TNFR1 associated death domain protein ,Signal Transduction ,IκB-α, alpha ,IL‐8, Interleukin-8 ,Coronavirus disease 2019 (COVID-19) ,Inflammation ,Biology ,MIP1B, Macrophage inflammatory protein-1 beta ,Ang I, Angiotensin I ,medicine ,BALF, Bronchoalveolar lavage fluid ,Ang II, Angiotensin II ,CXCR2, Chemokine receptor 2 ,AT1R, Angiotensin II type I receptor ,VLDLR, Very low-density lipoprotein receptors ,Gene ,miRNA ,NLRP3, NLR family pyrin domain containing 3 ,SARS-CoV-2 ,PCBP2, Poly (rC)-binding protein 2 ,B-cells inhibitor, Nuclear factor of kappa light polypeptide gene enhancer in ,IL‐1, Interleukin-1 ,COVID-19 ,ACE, Angiotensin-converting enzyme ,STAT, Signal transducers and activators of transcription ,TGF-β1, Transforming growth factor beta 1 ,NLR, Neutrophil to lymphocyte ratio ,JAK/STAT ,Review article ,MicroRNAs ,SOCS1, Suppressor of cytokine signaling 1 ,GCS-F, Granulocyte colony-stimulating factor ,MCP‐1, Monocyte chemoattractant protein-1 ,DPP4R, Dipeptidyl peptidase-4 receptor ,ESR, Erythrocyte sedimentation rate ,IFITM3, Interferon-induced transmembrane protein 3 - Abstract
COVID-19 is the cause of a pandemic associated with substantial morbidity and mortality. As yet, there is no available approved drug to eradicate the virus. In this review article, we present an alternative study area that may contribute to the development of therapeutic targets for COVID-19. Growing evidence is revealing further pathophysiological mechanisms of COVID-19 related to the disregulation of inflammation pathways that seem to play a critical role toward COVID-19 complications. The NF-kB and JAK/STAT signaling pathways are highly activated in acute inflammation, and the excessive activity of these pathways in COVID-19 patients likely exacerbates the inflammatory responses of the host. A group of non-coding RNAs (miRNAs) manage certain features of the inflammatory process. In this study, we discuss recent advances in our understanding of miRNAs and their connection to inflammatory responses. Additionally, we consider the link between perturbations in miRNA levels and the onset of COVID-19 disease. Furthermore, previous studies published in the online databases, namely web of science, MEDLINE (PubMed), and Scopus, were reviewed for the potential role of miRNAs in the inflammatory manifestations of COVID-19. Moreover, we disclosed the interactions of inflammatory genes using STRING DB and designed interactions between miRNAs and target genes using Cityscape software. Several miRNAs, particularly miR-9, miR-98, miR-223, and miR-214, play crucial roles in the regulation of NF-kB and JAK-STAT signaling pathways as inflammatory regulators. Therefore, this group of miRNAs that mitigate inflammatory pathways can be further regarded as potential targets for far-reaching-therapeutic strategies in COVID-19 diseases.
- Published
- 2021
28. How Immunonutritional Markers Are Associated with Age, Sex, Body Mass Index and the Most Common Chronic Diseases in the Hospitalized Geriatric Population—A Cross Sectional Study.
- Author
-
Stephenson, Serena S., Kravchenko, Ganna, Korycka-Błoch, Renata, Kostka, Tomasz, and Sołtysik, Bartłomiej K.
- Abstract
The aim of this study was to assess the relationship of different chronic diseases with immunonutritional markers in the senior population. Methods: this study included 1190 hospitalized geriatric patients. The criteria to participate were ability to communicate, given consent and C-reactive protein (CRP) lower than 6 mg/dL. Results: the mean age of the study population was 81.7 ± 7.6 years. NLR (neutrophil-to-lymphocyte ratio), LMR (lymphocyte-to-monocyte ratio), MWR (monocyte-to-white blood cell ratio), SII (systemic immune–inflammation index), PNI (prognostic nutritional index) and CAR (C-reactive protein-to-albumin ratio) were related to age. NLR and MWR were higher, while LMR, PLR (platelet-to-lymphocyte ratio and SII were lower in men. All markers were related to BMI. NLR, LMR, LCR (lymphocyte-to-CRP ratio), MWR, PNI and CAR were related to several concomitant chronic diseases. In multivariate analyses, age and BMI were selected as independent predictors of all studied immunonutritional markers. Atrial fibrillation, diabetes mellitus and dementia appear most often in the models. PNI presented the most consistent statistical association with age, BMI and concomitant chronic diseases. Conclusions: this study reveals the pivotal role of aging and BMI in inflammatory marker levels and the association of immunonutritional markers with different chronic diseases. Atrial fibrillation seems to have the most dominant connection to the immunonutritional markers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. The clinical value of nutritional and inflammatory indicators in predicting pneumonia among patients with intracerebral hemorrhage.
- Author
-
Zhao, Guang, Chen, Yuyang, Gu, Yuting, and Xia, Xiaohua
- Subjects
CEREBRAL hemorrhage ,NUTRITIONAL value ,MULTIPLE regression analysis ,RECEIVER operating characteristic curves ,NEUTROPHIL lymphocyte ratio - Abstract
Immunosuppression and malnutrition play pivotal roles in the complications of intracerebral hemorrhage (ICH) and are intricately linked to the development of stroke-associated pneumonia (SAP). Inflammatory markers, including NLR (neutrophil-to-lymphocyte ratio), SII (systemic immune inflammation index), SIRI (systemic inflammatory response index), and SIS (systemic inflammation score), along with nutritional indexes such as CONUT (controlling nutritional status) and PNI (prognostic nutritional index), are crucial indicators influencing the inflammatory state following ICH. In this study, our objective was to compare the predictive efficacy of inflammatory and nutritional indices for SAP in ICH patients, aiming to determine and explore their clinical utility in early pneumonia detection. Patients with severe ICH requiring ICU admission were screened from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The outcomes included the occurrence of SAP and in-hospital death. Receiver operating characteristic (ROC) analysis, multivariate logistic regression, smooth curve analysis, and stratified analysis were employed to investigate the relationship between the CONUT index and the clinical outcomes of patients with severe ICH. A total of 348 patients were enrolled in the study. The incidence of SAP was 21.3%, and the in-hospital mortality rate was 17.0%. Among these indicators, multiple regression analysis revealed that CONUT, PNI, and SIRI were independently associated with SAP. Further ROC curve analysis demonstrated that CONUT (AUC 0.6743, 95% CI 0.6079–0.7408) exhibited the most robust predictive ability for SAP in patients with ICH. Threshold analysis revealed that when CONUT < 6, an increase of 1 point in CONUT was associated with a 1.39 times higher risk of SAP. Similarly, our findings indicate that CONUT has the potential to predict the prognosis of patients with ICH. Among the inflammatory and nutritional markers, CONUT stands out as the most reliable predictor of SAP in patients with ICH. Additionally, it proves to be a valuable indicator for assessing the prognosis of patients with ICH. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. АНАЛІЗ ІНДЕКСІВ СИСТЕМНОГО ЗАПАЛЕННЯ НА ОСНОВІ ПОКАЗНИКІВ ПЕРИФЕРИЧНОЇ КРОВІ У ПЕРЕДЧАСНО НАРОДЖЕНИХ ДІТЕЙ ПРИ ПЕРИНАТАЛЬНІЙ ПАТОЛОГІЇ.
- Author
-
Годованець, О. С.
- Subjects
MONOCYTE lymphocyte ratio ,PLATELET lymphocyte ratio ,BIOETHICS ,BLOOD cell count ,PREMATURE infants ,CHORIOAMNIONITIS - Abstract
The analysis of hematological parameters in premature infants with clinical signs of perinatal pathology is important and allows to assess the adaptive response of the body, especially under the conditions of negative effects of hypoxia. Almost half of all preterm births are caused by inflammatory processes in the mother leading to rupture of membranes with or without chorioamnionitis. Due to the functional immaturity of organ systems and regulatory mechanisms, preterm infants have certain problems of adaptation in the neonatal period. Disruption of a balanced adaptive response to changing environmental conditions due to dysregulation of immune defense and immunosuppression is the basis for the initiation of pathophysiological mechanisms of hypoxic stress and damage to the body, starting from the subcellular level. This causes severe dysmetabolic changes with the formation of serious diseases with a high risk of mortality and the formation of long-term consequences of pathology in survivors, reducing the quality of life of patients in later years. Materials and methods. We studied 68 infants with a gestational age of 32 to 33/6 weeks who had clinical signs of perinatal pathology (main study group). Subgroup A included 35 newborns with severe disease, and subgroup B included 33 children whose general condition was considered moderate. The comparison group consisted of 31 infants with a gestational age of 34 to 36/6 weeks (control group). Inclusion criteria were confirmed clinical signs of moderate and severe perinatal pathology; exclusion criteria were gestational age at birth less than 32 weeks and 37 weeks or more, congenital malformations. A comprehensive clinical and laboratory examination of newborns was performed, considering the main and concomitant pathology. Based on the results of the complete blood count, the ratio of indicators was calculated: NLR (neutrophil to lymphocyte ratio), PLR (platelet to lymphocyte ratio), MLR (monocyte to lymphocyte ratio); as well as SII (systemic immune inflammation index); SIRI (systemic inflammation response index); PIV (platelet, neutrophil, monocyte and lymphocyte index). Taking into account the data obtained, the risk of deterioration of newborns’ condition in relation to perinatal risk factors was identified, the limits of indicators and indices of systemic hypoxic inflammation in relation to moderate and severe pathology were determined. Scientific research was conducted in accordance with the basic provisions of GCP (1996), the Convention of the Council of Europe on Human Rights and Biomedicine (April 4, 1997), the Declaration of Helsinki of the World Medical Association on the Ethical Principles for Research on Human Subjects (1964-2008), Order of the Ministry of Health of Ukraine No. 690 dated September 23, 2009 (as amended by Order of the Ministry of Health of Ukraine No. 523 dated July 12, 2012). Protocol of scientific research of the Biomedical Ethics Commission of BSMU dated September 12, 2015. Considering the complex subject of the research work, the informed consent of the parents of newborns was obtained after familiarization with the purpose, objectives and planned methods of laboratory and functional studies. Statistical processing of results was performed using STATISTICA software (StatSoft Inc., USA, version 10). Comparison of quantitative indicators with normal distribution was performed using Student’s t-test, and the probability of differences was considered statistically significant at p<0.001. Results of the study. The results of the study showed that in order to determine the severity of the general condition in premature infants, along with the assessment of clinical signs of pathology, it is advisable to conduct a detailed analysis of the results of a complete blood count with the study of the ratio of individual indicators and the determination of systemic inflammation indices. This allows to improve the approaches to differential diagnosis of the severity of neonatal diseases by using a low-cost conventional method, while obtaining more correct conclusions. The indicators of complete blood count in newborns confirm the presence of compensatory activation of erythroid, myeloid and granulocytic hematopoiesis in response to hypoxia in the early neonatal period. The obtained data showed significant differences from the control values, which correlated with the severity of the newborns’ condition. Reserves for improving the effectiveness of medical care for IPA should include the improvement of diagnostic measures to clarify the pathophysiological mechanisms of hypoxic inflammation in order to reduce mortality and prevent the development of long-term consequences of the pathology, while maintaining the health and quality of life of patients. Conclusions: 1. Determination of the ratio of GBT and systemic inflammatory indices can be a qualitative adjunct to diagnosis to clarify the pathophysiological mechanisms of hypoxic damage to the body and to objectify approaches to assessing the severity of the condition of newborns with various forms of perinatal pathology. 2. The risk of worsening in children with development of moderate pathology should be predicted at the following limits of the ratio of indicators: an increase in NLR from 0.295 to 0.343, a decrease in PLR from 7.982 to 7.290 and MLR from 0.096 to 0.093; an increase in systemic inflammation indices: SII – from 66.546 to 76.386, SIRI – from 0.802 to 0.975, PIV – from 180.825 to 225.130. 3. Severe course of diseases in newborns is predicted on the basis of ratio of indicators: NLR – up to 0.238, PLR – up to 5.923, MLR – up to 0.086 and the presence of systemic inflammation indices: SII – up to 51.230, SIRI – up to 0.745 and PIV – up to 160.310. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. An enlightening role for cytokine storm in coronavirus infection
- Author
-
Chuanmin Tao, Zhongyi Zhao, and Yinhao Wei
- Subjects
0301 basic medicine ,ALI, acute lung injury ,viruses ,CoV, coronavirus ,GCSF, granulocyte colony stimulating factor ,MIP1B, macrophage Inflammatory Protein 1 beta ,IFN, interferons ,Review Article ,medicine.disease_cause ,Severe Acute Respiratory Syndrome ,Cytokine storm ,TLRs, Toll-like receptors ,0302 clinical medicine ,DC, dendritic cell ,PRRs, pattern recognition receptors ,Immunology and Allergy ,Respiratory system ,COVID-CSS, COVID-19 related cytokine storm syndrome ,Coronavirus ,COVID-19, coronavirus disease 2019 ,Multiple organ dysfunctions ,TNF, tumor necrosis factor ,CCL, chemokine ligand ,GMCSF, granulocyte-macrophage colony-stimulating factor ,virus diseases ,Inflammatory cytokines ,STAT, signal transducer and activator of transcription ,medicine.anatomical_structure ,Severe acute respiratory syndrome-related coronavirus ,Middle East Respiratory Syndrome Coronavirus ,CRP, C-reactive protein ,MIP1A, macrophage Inflammatory Protein 1 Alpha ,NF-κB, nuclear factor κB ,Coronavirus Infections ,Cytokine Release Syndrome ,JAK, Janus kinase ,PBMC, peripheral blood mononuclear cell ,PDGF, platelet derived growth factor ,Middle East respiratory syndrome coronavirus ,IL-1RA, IL-1 receptor antagonist ,IP-10, IFN-γ-inducible protein-10 ,NLR, neutrophil-to-lymphocyte ratio ,Immunology ,Th2, T-helper-2 cell ,CNS, central nervous system ,BMSC, bone marrow stromal cell ,ACE2, angiotensin-converting enzyme 2 ,SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 ,WHO, World Health Organization ,Th, helper T cell ,Proinflammatory cytokine ,03 medical and health sciences ,IRF3, IFN regulatory factor-3 ,PAMPs, pathogen-associated molecular patterns ,medicine ,NK, natural killer cell ,Humans ,SARS, severe acute respiratory syndrome ,Adverse effect ,B, B lymphocyte ,ARDS, acute respiratory distress syndrome ,CXCL, chemokine (C-X-C motif) ligand ,VEGF, vascular endothelial cell growth factor ,business.industry ,SARS-CoV-2 ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MERS, Middle East respiratory syndrome ,Outbreak ,COVID-19 ,MCP, monocyte chemoattractant protein ,medicine.disease ,IL, interleukin ,FGF, fibroblast growth factor ,Coronavirus disease 2019 (COVID-19) ,Th1, T-helper-1 cell ,030104 developmental biology ,business ,030215 immunology ,Respiratory tract - Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in Wuhan, China has dispersed rapidly worldwide. Although most patients present with mild fever, cough with varying pulmonary shadows, a significant portion still develops severe respiratory dysfunction. And these severe cases are often associated with manifestations outside the respiratory tract. Currently, it is not difficult to find inflammatory cytokines upregulated in the blood of infected patients. However, some complications in addition to respiratory system with the coronavirus disease 2019 (COVID-19) are impossible to explain or cannot be attributed to virus itself. Thus excessive cytokines and their potentially fatal adverse effects are probably the answer to the multiple organ dysfunctions and growing mortality. This review provides a comprehensive overview of the mechanisms underlying cytokine storm, summarizes its pathophysiology and improves understanding of cytokine storm associated with coronavirus infections by comparing SARS-CoV-2 with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)., Highlights • In December 2019, a novel coronavirus of SARS-CoV-2 emerged in Wuhan, Hubei, China, rapidly dispersed and even exported to neighboring countries. • SARS-CoV-2 generally causes a mild lower respiratory tract infection in humans, however, in some sever cases, signs of dysfunctions in multiple organs have been discovered. • Overproduction of cytokines, termed cytokine storm, may involve in disease progression and even be responsible for deaths. • Application of immune-modulators might become a complement to support treatment and flip on the light switch for severe patients.
- Published
- 2021
- Full Text
- View/download PDF
32. A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer
- Author
-
Emne Ali Abdallah, Milena Shizue Tariki, Alexcia Camila Braun, Renata Mayumi Takahashi, Virgilio Souza e Silva, José Gabriel Rodríguez Tarazona, Bruna Elisa Catin Kupper, Samuel Aguiar Junior, Vanessa Alves Gasparini, and Ludmilla Thomé Domingos Chinen
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Original article ,CTM, circulating tumor microemboli ,Circulating tumor microemboli ,DFS, disease-free survival ,Colorectal cancer ,Lymphocyte ,NLR, neutrophil-to-lymphocyte ratio ,SE, sensitivity ,Disease ,CTC, circulating tumor cell ,lcsh:RC254-282 ,03 medical and health sciences ,AUC, area under the curve ,0302 clinical medicine ,Circulating tumor cell ,PLR, platelet-to-lymphocyte ratio ,Internal medicine ,medicine ,ISET, isolation by size of tumor cells ,Stage (cooking) ,Liquid biopsy ,Colon adenocarcinoma ,ACC, accuracy ,SP, specificity ,business.industry ,Circulating tumor cells ,Cancer ,medicine.disease ,Platelet-to-lymphocyte ratio ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,ROC, receiver operating characteristic ,030104 developmental biology ,medicine.anatomical_structure ,Tumor progression ,030220 oncology & carcinogenesis ,CRC, colorectal cancer ,CEA, carcinoembryonic antigen ,business ,pS, pathological stage - Abstract
Highlights • A high platelet-to-lymphocyte ratio (PLR; >124) before curative surgical resection was found to be associated with reduced disease-free survival (DFS) in non-metastatic colon cancer patients. • A high PLR was predominant among patients with circulating tumor microemboli (CTM). • This prospective study revealed a mechanism of interaction between circulating tumor cells (CTCs) and other blood components, and implicated platelets in CTC survival. • The present findings support the use of blood biomarkers to better identify and follow high-risk colon cancer patients., Colorectal cancer is a common and often deadly cancer. Circulating tumor cells (CTCs) have been implicated as a potentially valuable prognosis factor. The detection of circulating tumor microemboli (CTM) and of simple blood component parameters that reflect inflammatory status, such as the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR), may provide information about tumor progression. The aim of this study was to explore the importance of CTCs, CTM, PLR, and NLR prospectively in non-metastatic colon cancer progression. CTCs were enriched using ISETⓇ (Isolation by SizE of Tumor cells) and identified by immunocytochemical exclusion of leukocytes. We evaluated CTCs and blood cell parameters in a cohort of 69 stage I–III colon cancer patients (52.2% men; median age, 61 years; age range, 19–87 years) at a baseline timepoint prior to resection surgery. The median of CTC levels at baseline was 20 cells/8 mL (0–94) and higher levels were associated with CTM presence (p = 0.02). CTM were found in 18 (26.1%) patients. Of 18 stage I patients, 33.3% had CTM and of 51 stages II or III patients, 13.7% had CTM (p = 0.08). Patients with a high PLR (>124) were mostly (75.6%) diagnosed with high-risk stages II/III cancer (stages I/low-risk II, 24.4%; p = 0.014). All 8 patients that had disease recurrence during follow-up had a high PLR (p = 0.02 vs. low PLR). NLR was not significantly associated with disease stage or recurrence. The present results indicate that CTCs and PLR analyses may be clinically useful for colon cancer management and risk stratification.
- Published
- 2021
33. Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports
- Author
-
Yoshihiro Takeda, Akihito Okazaki, Kazuhiko Shibata, Keiichi Iwasa, and Kazuki Gohara
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,Lung adenocarcinoma ,medicine.medical_specialty ,medicine.medical_treatment ,NLR, neutrophil-to-lymphocyte ratio ,Case Report ,Pembrolizumab ,EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle aspiration ,OS, overall survival ,Diseases of the respiratory system ,PR, partial response ,NSCLC, non-small cell lung cancer ,Internal medicine ,TPS, tumor proportion score ,medicine ,Complete remission ,Lung cancer ,Lung ,RC705-779 ,business.industry ,ALK, anaplastic lymphoma kinase ,Therapeutic effect ,Immunotherapy ,CR, complete remission ,medicine.disease ,CT, computed tomography ,EGFR, epidermal growth factor receptor ,Clinical trial ,PD-L1, programmed death-ligand 1 ,medicine.anatomical_structure ,ICI, immune checkpoint inhibitors ,Adenocarcinoma ,RR, response rate ,business - Abstract
Immune checkpoint inhibitors (ICIs) are clinically used for treating advanced lung cancer, and some patients have achieved complete remission (CR) with ICI therapy in clinical trials. However, reports summarizing the clinical courses of such patients are limited. We report two cases of lung adenocarcinoma in which CR was achieved with first-line pembrolizumab monotherapy, and the therapeutic effect was maintained after treatment completion. Specific patients can achieve CR, even those who do not meet the previously reported predictors of treatment response other than high programmed death-ligand 1 expression. Thus, biomarkers that can accurately predict the clinical efficacy of ICIs are warranted.
- Published
- 2021
34. Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Coronavirus Disease 2019 Patients With Hyperinflammatory Phenotype
- Author
-
Chen, Hui, Xie, Jianfeng, Su, Nan, Wang, Jun, Sun, Qin, Li, Shusheng, Jin, Jun, Zhou, Jing, Mo, Min, Wei, Yao, Chao, Yali, Hu, Weiwei, Du, Bin, and Qiu, Haibo
- Subjects
corticosteroid ,LCA, latent class analysis ,SPO2, pulse oxygen saturation ,phenotype ,SARS-CoV-2 ,Critical Illness ,IPTW, inverse probability of treatment weighting ,COVID-19 ,Pao2, arterial oxygen partial pressure ,MSCM, marginal structural modeling ,HR, hazard ratio ,Adrenal Cortex Hormones ,Critical Care: Original Research ,Humans ,Steroids ,SARS, severe acute respiratory syndrome ,IQR, interquartile range ,NLR, neutrophil to lymphocyte ratio ,TNF-α, tumor necrosis factor α ,COVID-19, coronavirus disease 2019 ,SOFA, Sequential Organ Failure Assessment - Abstract
Background Corticosteroid therapy is used commonly in patients with coronavirus disease 2019 (COVID-19), although its impact on outcomes and which patients could benefit from corticosteroid therapy are uncertain. Research Question Are clinical phenotypes of COVID-19 associated with differential response to corticosteroid therapy? Study Design and Methods Critically ill patients with COVID-19 from Tongji Hospital treated between January and February 2020 were included, and the main exposure of interest was the administration of IV corticosteroids. The primary outcome was 28-day mortality. Marginal structural modeling was used to account for baseline and time-dependent confounders. An unsupervised machine learning approach was carried out to identify phenotypes of COVID-19. Results A total of 428 patients were included; 280 of 428 patients (65.4%) received corticosteroid therapy. The 28-day mortality was significantly higher in patients who received corticosteroid therapy than in those who did not (53.9% vs 19.6%; P < .0001). After marginal structural modeling, corticosteroid therapy was not associated significantly with 28-day mortality (hazard ratio [HR], 0.80; 95% CI, 0.54-1.18; P = .26). Our analysis identified two phenotypes of COVID-19, and compared with the hypoinflammatory phenotype, the hyperinflammatory phenotype was characterized by elevated levels of proinflammatory cytokines, higher Sequential Organ Failure Assessment scores, and higher rates of complications. Corticosteroid therapy was associated with a reduced 28-day mortality (HR, 0.45; 95% CI, 0.25-0.80; P = .0062) in patients with the hyperinflammatory phenotype. Interpretation For critically ill patients with COVID-19, corticosteroid therapy was not associated with 28-day mortality, but the use of corticosteroids showed significant survival benefits in patients with the hyperinflammatory phenotype.
- Published
- 2020
35. Proinflammatory cytokines predict the incidence of diabetic peripheral neuropathy over 5 years in Chinese type 2 diabetes patients: A prospective cohort study
- Author
-
Hongying Ye, Yuanpin Zhang, Bin Lu, Xiaoming Zhu, Lijin Ji, Qi Zhang, Wanwan Sun, Yiming Li, Hangping Zheng, Qian Xiong, Shuo Zhang, and Xiaoxia Liu
- Subjects
medicine.medical_specialty ,Research paper ,NLR, neutrophil-to-lymphocyte ratio ,DBP, diastolic blood pressure ,Type 2 diabetes ,IL-1RA, interleukin-1 receptor antagonist ,AST, aspartate aminotransferase ,01 natural sciences ,Proinflammatory cytokine ,HDL-C, high-density lipoprotein cholesterol ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Diabetes mellitus ,Internal medicine ,ALT, alanine aminotransferase ,DSPN, distal sensorimotor polyneuropathy ,Medicine ,MDRD, Modification of Diet in Renal Disease ,030212 general & internal medicine ,FPG, fasting plasma glucose ,0101 mathematics ,Predict ,Prospective cohort study ,Proinflammatory cytokines ,lcsh:R5-920 ,PPG, postprandial plasma glucose ,ACR, albumin-to-creatinine ratio ,business.industry ,Incidence (epidemiology) ,SBP, systolic blood pressure ,010102 general mathematics ,Hazard ratio ,General Medicine ,medicine.disease ,Diabetic peripheral neuropathy ,TG, triacylglycerol ,TC, total cholesterol ,Clinical research ,Peripheral neuropathy ,chemistry ,MNSI, Michigan Neuropathy Screening Instrument ,LDL-C, low-density lipoprotein cholesterol ,Glycated hemoglobin ,HbA1c, glycated hemoglobin ,lcsh:Medicine (General) ,business ,DPN, diabetic peripheral neuropathy ,Scr, serum creatinine - Abstract
Aims: Inflammation has been implicated in the pathogenesis of diabetic peripheral neuropathy (DPN) as suggested in various cross-sectional studies. However, more convincing prospective studies in diabetes patients are scarce. Therefore, we aimed to evaluate whether proinflammatory cytokines could predict the incidence of DPN through a prospective study with a five-year follow-up. Methods: We followed up 315 patients with diabetes who did not have DPN, recruited from five community health centers in Shanghai in 2014, for an average of 5.06 years. Based on the integrity of blood samples, 106 patients were selected to obtain the proinflammatory cytokines. Plasma markers of proinflammatory cytokines at baseline included interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), vascular endothelial growth factor (VEGF), and intercellular adhesion molecule 1 (ICAM-1). Neuropathy was assessed by MSNI at baseline and during follow-up. Results: Among the 106 randomly chosen patients, 63 developed DPN after 5.06±1.14 years of follow-up. The baseline plasma levels of TNF-α, IL-6, and ICAM-1 were higher in the neuropathic group (P
- Published
- 2020
36. Predictive Nomogram for Severe COVID-19 and Identification of Mortality-Related Immune Features
- Author
-
Xi Zhou, Huafang Wang, Shidai Mu, Yu Hu, Heng Mei, Lisha Ai, Xiaoyan Zhao, Miao Wang, Wei Chen, and Li Cai
- Subjects
Oncology ,medicine.medical_specialty ,IQR, Quartile interval ,AUC, Area under the ROC curve ,macromolecular substances ,ROC, Receiver operator characteristic ,Nomogram ,SARS-CoV, Severe acute respiratory syndrome coronavirus ,03 medical and health sciences ,0302 clinical medicine ,CD45RO+CD3+ T cells ,NK, Natural killer ,Internal medicine ,ARDS, Acute respiratory distress syndrome ,Immunology and Allergy ,Medicine ,030212 general & internal medicine ,Neutrophil to lymphocyte ratio ,biology ,Receiver operating characteristic ,business.industry ,CI, Confidence interval ,Mortality rate ,C-reactive protein ,Area under the curve ,COVID-19 ,COVID-19, 2019 novel coronavirus disease ,Odds ratio ,NNKR, Neutrophil-to-NK cell ratio ,030228 respiratory system ,Risk factors ,NLR, Neutrophil-to-lymphocyte ratio ,Immunological feature ,Cohort ,biology.protein ,CRP, C-reactive protein ,Original Article ,business ,OR, Odds ratio - Abstract
Background Patients with severe 2019 novel coronavirus disease (COVID-19) have a high mortality rate. The early identification of severe COVID-19 is of critical concern. In addition, the correlation between the immunological features and clinical outcomes in severe cases needs to be explored. Objective To build a nomogram for identifying patients with severe COVID-19 and explore the immunological features correlating with fatal outcomes. Methods We retrospectively enrolled 85 and 41 patients with COVID-19 in primary and validation cohorts, respectively. A predictive nomogram based on risk factors for severe COVID-19 was constructed using the primary cohort and evaluated internally and externally. In addition, in the validation cohort, immunological features in patients with severe COVID-19 were analyzed and correlated with disease outcomes. Results The risk prediction nomogram incorporating age, C-reactive protein, and D-dimer for early identification of patients with severe COVID-19 showed favorable discrimination in both the primary (area under the curve [AUC] 0.807) and validation cohorts (AUC 0.902) and was well calibrated. Patients who died from COVID-19 showed lower abundance of peripheral CD45RO+CD3+ T cells and natural killer cells, but higher neutrophil counts than that in the patients who recovered (P = .001, P = .009, and P = .009, respectively). Moreover, the abundance of CD45RO+CD3+ T cells, neutrophil-to-lymphocyte ratio, and neutrophil-to-natural killer cell ratio were strong indicators of death in patients with severe COVID-19 (AUC 0.933 for all 3). Conclusion The novel nomogram aided the early identification of severe COVID-19 cases. In addition, the abundance of CD45RO+CD3+ T cells and neutrophil-to-lymphocyte and neutrophil-to-natural killer cell ratios may serve as useful prognostic predictors in severe patients.
- Published
- 2020
37. Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19
- Author
-
Amir Roudgari, Mehrnoosh Doroudchi, Golnar Sabetian, Shahram Paydar, Najmeh Rokhtabnak, Hamed Fouladseresht, and Hossein Abdolrahimzadehfard
- Subjects
ssRNA, single-stranded RNA ,CT, computerized tomography ,Complications ,Endocrinology, Diabetes and Metabolism ,RA, rheumatoid arthritis ,Ab, antibody ,LY6E, lymphocyte antigen 6 family member E ,AT1R, Ang II receptor type 1 ,MDA-5, melanoma differentiation-associated protein-5 ,Immunopathology ,GzmB, granzyme B ,SAA, serum amyloid A ,SARS, severe acute respiratory ,Medicine ,DIC, disseminated intravascular coagulation ,ORF-1ab, open reading frame 1ab ,RT-qPCR, real-time PCR-quantitative PCR ,Fio2, fraction of inspired oxygen ,Lung ,COVID-19, coronavirus disease-2019 ,LDH, lactate dehydrogenase ,AICD, activation-induced cell death ,IRF-1, IFN regulatory factor 1 ,C3 and C5, complement proteins ,RBD, receptor-binding domain ,IP-10, interferon (IFN-γ inducible protein-10 ,CXCR, chemokine (C-X-C motifligand receptor ,Acquired immune system ,Prognosis ,KL-6, Krebs von den Lungen-6 ,JUN, c-Jun N-terminal kinases ,NSP, non-structural proteins ,Cytokines ,BEC, bronchial epithelial cell ,rhIL-1ra, recombinant human IL-1 receptor ,Antibody ,Cytokine Release Syndrome ,GM-CSF, granulocyte-macrophage colony-stimulating factor ,NK, natural killer ,WBC, white blood cell ,MOF, multiple organ failure ,CP, convalescent plasma ,PLR, platelet-to-lymphocyte ratios ,FcγR, Fc gamma receptor ,Immunology ,HLH, hemophagocytic lymphohistiocytosis ,General Biochemistry, Genetics and Molecular Biology ,Article ,PKR, protein kinase R ,MERS, middle east respiratory syndrome ,nAb, neutralizing antibody ,LWR, lymphocyte-to-WBCs ratio ,PT, prothrombin time ,IVIg, intravenous immunoglobulin ,Humans ,mAb, monoclonal antibody ,APTT, activated partial thromboplastin time ,NFkB, nuclear factor kappa-light-chain-enhancer of activated B cells ,ARDS, acute respiratory distress syndrome ,Monitoring, Physiologic ,ESR, erythrocyte sedimentation rate ,rIL7, recombinant IL-7 ,Pao2, partial pressure of oxygen ,rBP-C33, Leurecombinant surfactant protein C analogue ,HLA, human leukocyte antigen ,MUC, mucin ,scFv, single-chain variable fragment ,Biomarker ,medicine.disease ,CTL, cytotoxic T lymphocyte ,Immunity, Innate ,IL, interleukin ,RAS, regulator of the renin-angiotensin system ,Clinical trial ,TNF-α, tumor necrosis factor ,APC, antigen-presenting cell ,siRNA, small interfering RNA ,CXCL, chemokine (C-X-C motifligand ,PRR, pattern recognition receptors ,NLRP3, nod-like receptor protein 3 ,TMPRSS2, transmembrane serine protease 2 ,S-protein, spike-protein ,Biomarkers ,ACEI, ACE inhibitor ,LAG-3, lymphocyte-activation gene 3 ,MIP, macrophage inflammatory proteins ,Chemokine ,NCT, clinicaltrials.gov identifier ,CCL, chemokine (C-C motifligand ,TLR, toll like receptor ,CQ, chloroquine ,NKRF, NFkB repressing factor ,Cytokine storm ,C-GAS-STING, cGAMP binds to stimulator of interferon genes ,rhACE2-Fc fusion proteins, recombinant human ACE2-Fc fusion proteins ,srhACE2, soluble recombinant human (srhACE2 ,CRP, c-reactive protein ,BALF, bronchoalveolar lavage fluid ,Immunology and Allergy ,TGF, transforming growth factor ,Respiratory Distress Syndrome ,BTK, Bruton tyrosine kinase ,biology ,ICU, admissions to intensive care units ,IFITM, interferon-induced transmembrane protein ,PD1, programmed cell death protein 1 ,CRS, cytokine release syndrome ,VEGF, vascular endothelial growth factor ,ISG, induction of IFN-stimulated gene ,PCT, procalcitonin ,S1PR, sphingosine-1-phosphate receptors ,RIG, retinoic acid-inducible gene-I ,CCR, chemokine (C-C motifligand receptor ,TIM-3, T-cell immunoglobulin mucin 3 ,Ang, angiotensin ,Biomarker (medicine) ,AAK-1, activated protein (AP2 associated kinase 1 ,Chemokines ,AEC, alveolar epithelial cells ,ACE, angiotensin-converting enzyme ,SP, surfactant ,NLR, neutrophil-to-lymphocyte ratio ,SARS-CoV, severe acute respiratory syndrome coronavirus ,ChiCTR, chinese clinical trial registry ,JAK, janus kinase ,Th, helper T cell ,Immune system ,IFN, interferon ,NTD, N terminal domain ,ComputingMethodologies_COMPUTERGRAPHICS ,HR-2, heptad repeat region-2 ,business.industry ,SARS-CoV-2 ,COVID-19 ,HCQ, hydroxychloroquine ,SPo2, arterial oxygen saturation ,MCP, monocyte chemoattractant protein ,Treg, regulatory T cells ,RLR, RIG-I-like receptors ,biology.protein ,ARB, Ang II receptor blocker ,dsRNA, double-stranded RNA ,business ,GAK, G-associated kinase ,N, nucleocapsid - Abstract
Graphical abstract, The coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), appears with a wide spectrum of mild-to-critical clinical complications. Many clinical and experimental findings suggest the role of inflammatory mechanisms in the immunopathology of COVID-19. Hence, cellular and molecular mediators of the immune system can be potential targets for predicting, monitoring, and treating the progressive complications of COVID-19. In this review, we assess the latest cellular and molecular data on the immunopathology of COVID-19 according to the pathological evidence (e.g., mucus and surfactants), dysregulations of pro- and anti-inflammatory mediators (e.g., cytokines and chemokines), and impairments of innate and acquired immune system functions (e.g., mononuclear cells, neutrophils and antibodies). Furthermore, we determine the significance of immune biomarkers for predicting, monitoring, and treating the progressive complications of COVID-19. We also discuss the clinical importance of recent immune biomarkers in COVID-19, and at the end of each section, recent clinical trials in immune biomarkers for COVID-19 are mentioned.
- Published
- 2020
38. The characteristics and outcomes of 681 severe cases with COVID-19 in China
- Author
-
De zhen Su, Xiao Meng, Yi Zhang, Ya Liu, Fang fang Chen, Ming Zhong, Kai Zhang, and Yun Zhang
- Subjects
Male ,Indoles ,CD3 Complex ,Neutrophils ,CAD, coronary artery disease ,Angiotensin-Converting Enzyme Inhibitors ,AST, aspartate aminotransferase ,Disease ,Critical Care and Intensive Care Medicine ,HDL-C, high density lipoprotein cholesterol ,chemistry.chemical_compound ,0302 clinical medicine ,Epidemiology ,Lymphocytes ,BNP, brain natriuretic peptide ,IFN-α, Interferon-α ,LDH, lactate dehydrogenase ,TG, triglyceride ,NLR, Neutrophil-To-Lymphocyte Ratio ,Treatments ,Middle Aged ,Cardiovascular disease ,ARB, angiotensin receptor blocker ,C-Reactive Protein ,CK-MB, creatine kinase-myocardial isoenzyme ,Area Under Curve ,CRP, C-reactive protein ,Female ,Outcome data ,LDL-C, low density lipoprotein cholesterol ,Adult ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,China ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,DBP, diastolic blood pressure ,Article ,cTnI, cardiac troponin I ,03 medical and health sciences ,Angiotensin Receptor Antagonists ,Young Adult ,ALT, alanine aminotransferase ,Internal medicine ,Lactate dehydrogenase ,Ribavirin ,medicine ,Humans ,Lymphocyte Count ,IL-6, Interleukin-6 ,Aged ,Retrospective Studies ,Clinical characteristics ,L-Lactate Dehydrogenase ,SARS-CoV-2 ,business.industry ,COVID, coronavirus disease ,SBP, systolic blood pressure ,CKD, chronic kidney disease ,COVID-19 ,030208 emergency & critical care medicine ,COVID-19 Drug Treatment ,TC, total cholesterol ,COPD, chronic obstructive pulmonary disease ,030228 respiratory system ,chemistry ,ROC Curve ,Multivariate Analysis ,ACEI, angiotensin-converting enzyme inhibitor ,business - Abstract
Purpose To clarify the epidemiological, clinical, and therapeutic features of patients with severe COVID-19. Methods In this study, we enrolled 681 patients with confirmed cases of severe COVID-19. The epidemiological, demographic, clinical, laboratory, treatment, and outcome data were collected. Results The median age of the study participants was 65 years, 53.2% were male, and 104 (15.3%) died. Age, Neutrophil-To-Lymphocyte Ratio (NLR), acute myocardial injury, and levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), and CD3 T cells counts were independently and negatively associated with death, while arbidol and ribavirin were protective from death. The combination of NLR and acute myocardial injury on admission (AUC = 0.914) predicted mortality better than NLR, CRP, LDH, and acute myocardial injury. There were 312 (45.8%) patients with cardiovascular disease, of whom 23.4% died. β-blockers, ACEI/ARB, arbidol, and ribavirin might have a beneficial effect for severe COVID-19 patients with cardiovascular disease. Conclusion The combination of NLR and acute myocardial injury on admission was highly predictive of mortality and survival. Clinicians should adopt more aggressive strategies for patients with a high NLR (>6.66) combined with myocardial injury. β-blockers and ACEI/ARB, as well as arbidol and ribavirin, were effective in COVID-19 patients with cardiovascular disease., Highlights • Combination of NLR and acute myocardial injury could predict mortality. • Patients combined with higher NLR and myocardial injury need aggressive strategies. • Arbidol and ribavirin may be benefit to severe COVID-19. • β-blockers and ACEI/ARB are effective for patients with cardiovascular disease.
- Published
- 2020
39. Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle
- Author
-
Puja Ohri, Ajaz Ahmad, Renu Bhardwaj, Sukhmeen Kaur Kohli, Abhay Bhardwaj, Anket Sharma, Kanika Khanna, Parvaiz Ahmad, Ravdeep Kaur, and Vinay Bhardwaj
- Subjects
ACTH, adrenocorticotrophic hormones ,Battle ,viruses ,Tfh, follicular helper T-cells ,Pharmaceutical Science ,Review ,MT, metalloprotease ,APC, antigen presenting cell ,Natural therapeutics ,0302 clinical medicine ,GCSF, granulocyte-colony stimulating factor ,Drug Discovery ,Pandemic ,CHM, Chinese herbal medicine ,NF, neuro fibromatosis ,Medicine, Chinese Traditional ,NLRP3, NOD-like receptor proteins ,PDB, protein data bank ,media_common ,0303 health sciences ,TNF, tumor necrosis factor ,ARC, artepillin C ,Social distance ,RBD, receptor-binding domain ,R0, basic reproduction number ,030220 oncology & carcinogenesis ,Molecular Medicine ,MIP1, macrophage inflammatory protein 1 ,WHO, World Health Organisation ,NK, natural killer ,SARS-CoV, severe acute respiratory syndrome ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,media_common.quotation_subject ,AYUSH, ayurvedic, yoga and naturopathy, unani, siddha and homeopathy ,NLR, neutrophil-to-lymphocyte ratio ,IgG, immunoglobulin G ,ACE2, angiotensin-converting enzyme ,MVD, molegro virtual docker ,03 medical and health sciences ,Globalization ,Adjuvants, Immunologic ,Political science ,Immune-System Rebooting ,Development economics ,MAPK, mitogen activated protein kinases ,MCP1, monocytechemoattractant protein 1 ,medicine ,TCM, traditional Chinese medicines ,Humans ,PAK-1 Blockers ,C-1, Caspase-1 ,MERS-CoV, middle east respiratory syndrome ,Pandemics ,ARDS, acute respiratory distress syndrome ,030304 developmental biology ,Pharmacology ,ICTV, international committee on taxonomy of viruses ,Plants, Medicinal ,SARS-CoV-2 ,Public health ,fungi ,COVID-19 ,Traditional medicine ,IL, interleukin ,Medicine, Ayurvedic ,COVID-19 Drug Treatment ,Herbal plants ,IgM, immunoglobulin M ,Complementary and alternative medicine ,ASCs, antibody-secreting cells ,Immune System ,Dietary Supplements ,RNA, ribonucleic acid ,CAPE, caffeic acid phenyl ester ,Plant Preparations ,SARS-CoV-2, severe acute respiratory syndrome coronavirus-2 ,Phytotherapy - Abstract
Highlights • Coronavirus pandemic has created a global alarming situation. • SARS-CoV shares sequence homology with bats, therefore, considered as origin. • Scientists are burning midnight's oil to discover drug or vaccine against this deleterious virus. • Medicinal plants should be explored to find a cure for this disease. • Phyto-constituents are ubiquitously synthesised in plants, effective against SARS-CoV-2. • Clinical trials for herbal formulations are promoted to find drug or vaccine. • Other armours like physical fitness, balanced diet are promoted for boosting immunity., Current scenario depicts that world has been clenched by COVID-19 pandemic. Inevitably, public health and safety measures could be undertaken in order to dwindle the infection threat and mortality. Moreover, to overcome the global menace and drawing out world from moribund stage, there is an exigency for social distancing and quarantines. Since December, 2019, coronavirus, SARS-CoV-2 (COVID-19) have came into existence and up till now world is still in the state of shock.At this point of time, COVID-19 has entered perilous phase, creating havoc among individuals, and this has been directly implied due to enhanced globalisation and ability of the virus to acclimatize at all conditions. The unabated transmission is due to lack of drugs, vaccines and therapeutics against this viral outbreak. But research is still underway to formulate the vaccines or drugs by this means, as scientific communities are continuously working to unravel the pharmacologically active compounds that might offer a new insight for curbing infections and pandemics. Therefore, the topical COVID-19 situation highlights an immediate need for effective therapeutics against SARS-CoV-2. Towards this effort, the present review discusses the vital concepts related to COVID-19, in terms of its origin, transmission, clinical aspects and diagnosis. However, here, we have formulated the novel concept hitherto, ancient means of traditional medicines or herbal plants to beat this pandemic., Graphical abstract Image, graphical abstract
- Published
- 2020
40. Correction to: The value of CA125 in predicting acute complicated colonic diverticulitis.
- Author
-
Zager, Yaniv, Khalilieh, Saed, Mansour, Aiham, Cohen, Karin, Nadler, Roy, Anteby, Roi, Ram, Edward, Horesh, Nir, Nachmany, Ido, Gutman, Mordechai, and Berger, Yaniv
- Subjects
DIVERTICULITIS ,NEUTROPHIL lymphocyte ratio - Abstract
1Correlation between CA125 levels and severity of diverticulitis: A simple versus complicated diverticulitis; B CA125 levels according to the modified Hinchey classification. AUC, area under the curve; CRP, C-reactive protein; NLR, neutrophil to lymphocyte ratio; WBC, white blood count The original article has been corrected. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
41. Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study
- Author
-
Theodora A. Koulis, Susan P. Lees-Miller, Anthony M. Magliocco, Robyn Banerjee, Elizabeth N. Kornaga, Tien Phan, Prafull Ghatage, and Corinne M. Doll
- Subjects
0301 basic medicine ,medicine.medical_specialty ,PTHgb, pre-treatment hemoglobin ,Leukocytosis ,Anemia ,Plt, platelet ,NLR, neutrophil-to-lymphocyte ratio ,R895-920 ,LDR, low dose rate ,AOTHgb, average on treatment hemoglobin ,Gastroenterology ,Article ,OS, overall survival ,Medical physics. Medical radiology. Nuclear medicine ,HDR, high dose rate ,03 medical and health sciences ,0302 clinical medicine ,PA, paraortic ,Internal medicine ,EBRT, external beam radiotherapy ,medicine ,Radiology, Nuclear Medicine and imaging ,Neutrophil to lymphocyte ratio ,RC254-282 ,Thrombocytosis ,Cervical cancer ,business.industry ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Retrospective cohort study ,Prognosis ,medicine.disease ,CRT, chemoradiotherapy ,Surgery ,030104 developmental biology ,BT, brachytherapy ,Oncology ,030220 oncology & carcinogenesis ,Hgb, hemoglobin ,PFS, progression free survival ,Cohort ,medicine.symptom ,business ,Chemoradiotherapy ,WBC, white blood cell - Abstract
Introduction: Anemia has long been associated with poor prognosis in patients with cervical cancer. Recently, additional hematologic parameters have emerged as potential indicators of worse outcome in this patient group. In a cohort of cervical cancer patients treated with chemoradiotherapy (CRT) and brachytherapy, we report on the prognostic significance of hematologic parameters including anemia, leukocytosis, neutrophil to lymphocyte ratio (NLR), and thrombocytosis, the effect of combining anemia with other hematologic parameters, and the effect of changes in hemoglobin levels during treatment. Materials and methods: Two-hundred fifty-seven cervical cancer patients were retrospectively identified from a single cancer institution’s database. Hematologic parameters were categorized as: anemia (hemoglobin ≤115 g/L), leukocytosis (white blood cell count >10 × 109/L), thrombocytosis (platelets >400 × 109/L), and NLR (ratio >5). The association between clinical factors and hematologic parameters on progression-free survival (PFS) and overall survival (OS) were assessed at 5 years. Results: At 5 years, both pre-treatment anemia (PFS: 60% vs 34%, p
- Published
- 2017
- Full Text
- View/download PDF
42. Sequential Evaluation of Hematology Markers as a Prognostic Factor in Glioblastoma Patients.
- Author
-
Gonçalves, João Meira, Carvalho, Bruno, Tuna, Rui, Polónia, Patricia, and Linhares, Paulo
- Subjects
PROGNOSIS ,PLATELET lymphocyte ratio ,OVERALL survival ,NEUTROPHIL lymphocyte ratio ,GLIOBLASTOMA multiforme - Abstract
In our study, we investigated the prognostic significance of hematological markers—NLR (Neutrophil-to-Lymphocyte Ratio), PLR (Platelet-to-Lymphocyte Ratio), and RDW-CV (Red Blood Cell Distribution Width—Coefficient of Variation)—in 117 glioblastoma patients. The data collected from January 2016 to December 2018 included demographics, clinical scores, and treatment regimens. Unlike previous research, which often examined these markers solely before surgery, our unique approach analyzed them at multiple stages: preoperative, postoperative, and before adjuvant therapies. We correlated these markers with the overall survival (OS) and progression-free survival (PFS) using statistical tools, including ANOVA, Cox regression, and Kaplan–Meier survival analyses, employing SPSS version 29.0. Our findings revealed notable variations in the NLR, PLR, and RDW-CV across different treatment stages. The NLR and PLR decreased after surgery, with some stabilization post-STUPP phase (NLR: p = 0.007, η
2 p = 0.06; PLR: p = 0.001, η2 p = 0.23), while the RDW-CV increased post-surgery and during subsequent treatments (RDW-CV: p < 0.001, η2 p = 0.67). Importantly, we observed significant differences between the preoperative phase and other treatment phases. Additionally, a higher NLR and RDW-CV at the second-line treatment and disease progression were associated with an increased risk of death (NLR at 2nd line: HR = 1.03, p = 0.029; RDW-CV at progression: HR = 1.14, p = 0.004). We proposed specific marker cut-offs that demonstrated significant associations with survival outcomes when applied to Kaplan–Meier survival curves (NLR at 2nd line < 5: p < 0.017; RDW-CV at progression < 15: p = 0.007). An elevated NLR and RDW-CV at later treatment stages correlated with poorer OS and PFS. No significant preoperative differences were detected. These biomarkers may serve as non-invasive tools for glioblastoma management. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
43. The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.
- Author
-
Guo, Longxiang, Liu, Ao, Geng, Xiaotao, Zhao, Zongxing, Nie, Yu, Wang, Lu, Liu, Defeng, Li, Yi, Li, Yuanlin, Li, Dianxing, Wang, Qiankun, Li, Zhichao, Liu, Xiuli, and Li, Minghuan
- Subjects
DIAGNOSIS of esophageal cancer ,SQUAMOUS cell carcinoma ,RECEIVER operating characteristic curves ,RESEARCH funding ,RADIOMICS ,COMPUTED tomography ,STATISTICAL sampling ,TREATMENT effectiveness ,RETROSPECTIVE studies ,CANCER patients ,SPLEEN ,MATHEMATICAL models ,THEORY ,PROGRESSION-free survival ,ESOPHAGEAL cancer ,PROPORTIONAL hazards models ,OVERALL survival - Abstract
Background: The spleen plays an important role in systemic antitumor immune response, but whether spleen imaging features have predictive effect for prognosis and immune status was unknown. The aim of this study was to investigate computed tomography (CT)‐based spleen radiomics to predict the prognosis of patients with esophageal squamous cell carcinoma (ESCC) underwent definitive radiotherapy (dRT) and to try to find its association with systemic immunity. Methods: This retrospective study included 201 ESCC patients who received dRT. Patients were randomly divided into training (n = 142) and validation (n = 59) groups. The pre‐ and delta‐radiomic features were extracted from enhanced CT images. LASSO‐Cox regression was used to select the radiomics signatures most associated with progression‐free survival (PFS) and overall survival (OS). Independent prognostic factors were identified by univariate and multivariate Cox analyses. The ROC curve and C‐index were used to evaluate the predictive performance. Finally, the correlation between spleen radiomics and immune‐related hematological parameters was analyzed by spearman correlation analysis. Results: Independent prognostic factors involved TNM stage, treatment regimen, tumor location, pre‐ or delta‐Rad‐score. The AUC of the delta‐radiomics combined model was better than other models in the training and validation groups in predicting PFS (0.829 and 0.875, respectively) and OS (0.857 and 0.835, respectively). Furthermore, some spleen delta‐radiomic features are significantly correlated with delta‐ALC (absolute lymphocyte count) and delta‐NLR (neutrophil‐to‐lymphocyte ratio). Conclusions: Spleen radiomics is expected to be a useful noninvasive tool for predicting the prognosis and evaluating systemic immune status for ESCC patients underwent dRT. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study.
- Author
-
Okubo, So, Shinmura, Kohei, Kadota, Saori, Nakayasu, Misa, Kurosawa, Shuhei, Nakayama, Hitomi, Sakurai, Aki, Ito, Chisako, Aisa, Yoshinobu, and Nakazato, Tomonori
- Subjects
NON-Hodgkin's lymphoma ,OLDER patients ,BIOELECTRIC impedance ,CACHEXIA ,RECEIVER operating characteristic curves - Abstract
Cancer cachexia is a disorder that affects patient outcomes. The present study prospectively evaluated the prognostic value of the cachexia index (CXI) in elderly patients with non-Hodgkin's lymphoma (NHL). We prospectively analyzed 51 elderly patients who were diagnosed with NHL at our institution. CXI was calculated as follows: CXI = SMI × Alb/NLR (SMI: skeletal muscle index, Alb: serum albumin, NLR: neutrophil-to-lymphocyte ratio). SMI was measured by a bioelectrical impedance analysis (BIA) using the InBody 720. We determined the sex-specific cutoff values of the CXI by a receiver operating characteristic curve analysis and divided all patients into low- and high-CXI groups. The median age at the diagnosis was 78 years (60–93 years), and 28 (55%) were male. The histologic subtypes were B-cell lymphoma in 49 patients and T-cell lymphoma in 2. Twenty-eight (55%) patients were categorized into the high-CXI group, and 23 (45%) were categorized into the low-CXI group. The overall survival (OS) in the low-CXI group was significantly shorter than that in the high-CXI group (3-year OS, 70.4% vs. 95.7%, p = 0.007). Among 23 patients with DLBCL, patients with low-CXI had shorter OS than those with high-CXI (3-year OS, 55.6% vs. 92.9%, p = 0.008). On the other hand, sarcopenia had less impact on the clinical outcome of DLBCL patients. Low-CXI was associated with poor outcomes in elderly NHL and the CXI may be a clinical useful index for predicting prognosis. Further large prospective studies are needed to verify this conclusion. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Enhancing Pulmonary Embolism Mortality Risk Stratification Using Machine Learning: The Role of the Neutrophil-to-Lymphocyte Ratio.
- Author
-
Teodoru, Minodora, Negrea, Mihai Octavian, Cozgarea, Andreea, Cozma, Dragoș, and Boicean, Adrian
- Subjects
NEUTROPHIL lymphocyte ratio ,PULMONARY embolism ,MACHINE learning ,LEUKOCYTES ,HOSPITAL mortality - Abstract
(1) Background: Acute pulmonary embolism (PE) is a significant public health concern that requires efficient risk estimation to optimize patient care and resource allocation. The purpose of this retrospective study was to show the correlation of NLR (neutrophil-to-lymphocyte ratio) and PESI (pulmonary embolism severity index)/sPESI (simplified PESI) in determining the risk of in-hospital mortality in patients with pulmonary thromboembolism. (2) Methods: A total of 160 patients admitted at the County Clinical Emergency Hospital of Sibiu from 2019 to 2022 were included and their hospital records were analyzed. (3) Results: Elevated NLR values were significantly correlated with increased in-hospital mortality. Furthermore, elevated NLR was associated with PESI and sPESI scores and their categories, as well as the individual components of these parameters, namely increasing age, hypotension, hypoxemia, and altered mental status. We leveraged the advantages of machine learning algorithms to integrate elevated NLR into PE risk stratification. Utilizing two-step cluster analysis and CART (classification and regression trees), several distinct patient subgroups emerged with varying in-hospital mortality rates based on combinations of previously validated score categories or their defining elements and elevated NLR, WBC (white blood cell) count, or the presence COVID-19 infection. (4) Conclusion: The findings suggest that integrating these parameters in risk stratification can aid in improving predictive accuracy of estimating the in-hospital mortality of PE patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis
- Author
-
Arvind Tomar, Ashad Narayanan, Savneet Kaur, Chaggan Bihari, Ekta Gupta, Sadam Hussain, Guresh Kumar, Dinesh M. Tripathi, Rakhi Maiwall, Meenu Bajpai, Kailash Kolhe, Pratibha Kale, and Shiv Kumar Sarin
- Subjects
Liver Cirrhosis ,medicine.medical_specialty ,Endothelial Injury ,Cirrhosis ,Ang1, Angiopoietin 1 ,RC799-869 ,Gastroenterology ,Article ,MELD, Model for End-Stage Liver Disease ,Procalcitonin ,SOFA, The Sequential Organ Failure Assessment ,law.invention ,Sepsis ,Model for End-Stage Liver Disease ,Von Willebrand factor ,law ,Internal medicine ,Internal Medicine ,medicine ,Immunology and Allergy ,Vegfr1, Vascular endothelial growth factor receptor 1 ,Neutrophil to lymphocyte ratio ,Covid-19, Coronavirus induced disease-19 ,SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 ,LDH, Lactate Dehydrogenase ,Hepatology ,biology ,business.industry ,ALT, Alanine aminotransferase ,Area under the curve ,COVID-19 ,NLR, Neutrophil to Lymphocyte Ratio ,ICAM1, Intercellular adhesion molecule 1 ,Diseases of the digestive system. Gastroenterology ,medicine.disease ,Intensive care unit ,vWF, von Willebrand Factor antigen ,CCI, Charles Comorbidity Index ,PCT, Procalcitonin ,ICU, Intensive care unit ,HR, Hazard Ratio ,Ang2, Angiopoietin 2 ,biology.protein ,AST, Aspartate aminotransferase ,business ,Biomarkers - Abstract
Background and Aims Endothelial injury and dysfunction play a detrimental role in the pathogenesis of infections. Endothelium-related molecules have been reported as potential biomarkers for early diagnosis and/or prognosis of infections. The prognostic value of these biomarkers in patients with liver cirrhosis and infections however remain elusive. Methods In this study, we investigated the performance of key soluble endothelial injury biomarkers, including intercellular adhesion molecule 1 (ICAM1), von Willebrand Factor (vWF) antigen, vascular endothelial growth factor receptor 1 (vegfr1), angiopoietin 1 and 2 (Ang1, 2) as mortality predictors in liver cirrhosis patients with severe covid-19 or bacterial sepsis. Results A total of 66 hospitalized patients [admitted in covid-19 ward or liver intensive care unit (ICU)] were included. 22 patients had covid-19 alone while 20 patients had cirrhosis plus covid-19. 24 patients had liver cirrhosis plus bacterial sepsis. Among cirrhosis patients, most common aetiology was alcohol. ICAM1 was increased (p=0.003) while vegfr1 (p, Graphical abstract
- Published
- 2021
- Full Text
- View/download PDF
47. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
- Author
-
Atieh Pourbagheri-Sigaroodi, Naeimeh Tavakolinia, Nader Bagheri, Mahda Delshad, Davood Bashash, and Ava Safaroghli-Azar
- Subjects
0301 basic medicine ,NKG2D, Natural killer G2D ,GrB, Granzyme B ,GrA, Granzyme A ,Lymphocyte ,MAPK, Mitogen-activated protein kinase ,FoxP3, Forkhead box P3 ,Review ,Disease ,Ig, Immunoglobulin ,medicine.disease_cause ,0302 clinical medicine ,AID, Activation-induced cytidine deaminase ,TNF-α, Tumor necrosis factor-α ,Immunology and Allergy ,PLR, Platelet to lymphocyte ratio ,IL, Interleukin ,Lymphocytes ,SP, Spike protein ,Coronavirus ,DI, Dengue infection ,TCR, T cell receptor ,ALC, Atypical lymphocytes ,Prognosis ,FACS, Fluorescence-activated cell sorting ,Pathophysiology ,ICS, Intracellular cytokine staining ,NK cell, Natural killer cell ,ICU, Intensive care unit ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Bcl-6, B cell lymphoma 6 ,CRP, C-reactive protein ,medicine.symptom ,JAK, Janus kinase ,ADE, Antibody-dependent enhancement ,SOS1, Son of sevenless homolog 1 ,TIM-3, T cell immunoglobulin and mucin domain-3 ,BALF, Broncho alveolar lavage fluid ,PD-1, Programmed cell death protein 1 ,CM T cell, Central memory T cells ,Immunology ,CAR-NK, Chimeric antigen receptor-engineered NK cell ,EM T cell, Effector memory T cells ,NKG2A, Natural killer G2A ,Tregs, Regulatory T cells ,SARS-CoV, Severe acute respiratory syndrome coronavirus ,cTFH, Circulating follicular helper T cells ,WHO, World health organization ,03 medical and health sciences ,Immune system ,Pharmacotherapy ,Lymphopenia ,ACE2, Angiotensin-converting enzyme 2 ,ARDS, Acute respiratory distress syndrome ,TH1, T helper type 1 ,medicine ,Humans ,TLM, Time to lymphocyte model ,AHF, Acute heart failure ,SGLT2, Sodium-glucose cotransporter-2 ,ComputingMethodologies_COMPUTERGRAPHICS ,Pharmacology ,SARS-CoV-2 ,STAT, Signal transducer and activator of transcription ,Septic shock ,business.industry ,Organ dysfunction ,COVID-19 ,PB, Peripheral blood ,COVID-19, Coronavirus disease-19 ,MSCs, Mesenchymal stem cells ,NLR, Neutrophil to lymphocyte ratio ,TFH, T follicular helper cells ,medicine.disease ,Lymphocyte Subsets ,COVID-19 Drug Treatment ,FasL, Fas ligand ,030104 developmental biology ,MHC-II, Major histocompatibility complex-class II ,sCD25, Soluble CD25 (interleukin-2 receptor) ,RBD, Receptor-binding domain ,AIM assays, Analysis of activation induced marker ,business ,IL-2Ra, Interleukin-2 receptor alpha - Abstract
Graphical abstract, The incidence of the novel coronavirus disease (COVID-19) outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has brought daunting complications for people as well as physicians around the world. An ever-increasing number of studies investigating the characteristics of the disease, day by day, is shedding light on a new feature of the virus with the hope that eventually these efforts lead to the proper treatment. SARS-CoV-2 activates antiviral immune responses, but in addition may overproduce pro-inflammatory cytokines, causing uncontrolled inflammatory responses in patients with severe COVID-19. This condition may lead to lymphopenia and lymphocyte dysfunction, which in turn, predispose patients to further infections, septic shock, and severe multiple organ dysfunction. Therefore, accurate knowledge in this issue is important to guide clinical management of the disease and the development of new therapeutic strategies in patients with COVID-19. In this review, we provide a piece of valuable information about the alteration of each subtype of lymphocytes and important prognostic factors associated with these cells. Moreover, through discussing the lymphopenia pathophysiology and debating some of the most recent lymphocyte- or lymphopenia-related treatment strategies in COVID-19 patients, we tried to brightening the foreseeable future for COVID-19 patients, especially those with severe disease.
- Published
- 2021
- Full Text
- View/download PDF
48. Neutrophil-to-lymphocyte ratio and short-term mortality in patients having anti-MDA5-positive dermatomyositis with interstitial lung disease: a retrospective study.
- Author
-
Xin, Hongxia, He, Ping, Xi, Bin, Wang, Zhaojun, Wang, Han, Wang, Faxuan, Ma, Zhanbing, Xue, Jing, Jia, Yuanyuan, Cai, Hourong, Chen, Bi, and Chen, Juan
- Subjects
INTERSTITIAL lung diseases ,NEUTROPHIL lymphocyte ratio ,LOGISTIC regression analysis ,DERMATOMYOSITIS ,DEATH rate - Abstract
Background: In this study, we aimed to explore the association between baseline and early changes in the neutrophil-to-lymphocyte ratio (NLR) and the 30-day mortality rate in patients having anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis with interstitial lung disease (DM-ILD). Methods: Overall, 263 patients with anti-MDA5 DM-ILD from four centers in China were analyzed. Multivariate logistic regression analysis was used to evaluate the impact of baseline NLR on the 30-day mortality rate in patients with anti-MDA5-positive DM-ILD. Furthermore, a generalized additive mixed model (GAMM) was applied to compare the NLR variations over time between 30-day survival group and non-survival group. Results: Two hundred sixty-three patients with anti-MDA5-positive DM-ILD were divided into different groups based on their NLR and whether they survived or not within 30 days. The multivariate logistic regression analysis, accounting for confounding factors, identified an elevated baseline NLR as a prognostic indicator for 30-day mortality in patients with anti-MDA5-positive DM-ILD (hazard ratio 2.68, 95% confidence interval [CI] 1.18,6.00, P = 0.019). Furthermore, the GAMM results indicated that the NLR gradually increased more in the non-survival group compared with the survival group within 14 days of admission, with a daily average increase of 1.03 (β = 1.03; 95% CI, 0.75–1.31; P < 0.001). Conclusions: We found that an elevated baseline NLR and its progressive increase are associated with 30-day mortality in patients with anti-MDA5-positive DM-ILD. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF
49. Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study
- Author
-
Yan, Zhang, Pengfei, Zou, Hainv, Gao, Meifang, Yang, Ping, Yi, Jianhe, Gan, Yinzhong, Shen, Weihong, Wang, Wenhong, Zhang, Jun, Li, Peng, Liu, and Lanjuan, Li
- Subjects
AIV-H7N9 ,fungi ,NLR (neutrophil-to-lymphocyte ratio) ,biomarker ,influenza A ,Original Research - Abstract
Background: Avian AIV-H7N9 influenza progresses rapidly and has a high fatality rate. However, it lacks an early effective biomarker to predict disease severity and fatal outcomes successfully. Our study aimed to explore whether the neutrophil-to-lymphocyte ratio (NLR) taken within 24 h after admission can predict disease severity and fatality in AIV-H7N9-infected patients. Methods: We retrospectively studied 237 AIV-H7N9-infected patients from multiple centers from 2013 to 2015. We used univariate analysis and multivariate analysis to compare clinical variables between the survival and fatal groups to evaluate the prognostic value. Results: The NLR taken within 24 h after admission in the fatal group was significantly higher than that in the survival group (P
- Published
- 2019
50. Muscle Dysfunction and Functional Status in COVID-19 Patients during Illness and after Hospital Discharge.
- Author
-
Psenicka, Otakar, Brutvan, Tomas, Kratky, Jan, and Krizova, Jarmila
- Subjects
COVID-19 pandemic ,FUNCTIONAL status ,COVID-19 ,HOSPITAL admission & discharge ,RECTUS femoris muscles ,QUADRICEPS muscle - Abstract
Background: COVID-19 pneumonia is associated with SIRS and hypercatabolism. The aim of this study was to determine muscle loss during the acute phase of COVID-19 pneumonia and evaluate long-term sequelae in discharged patients. Methods: A total of 16 patients with COVID-19 pneumonia and respiratory insufficiency were included in the study. Selected parameters (weight, BMI, LBM = lean body mass, albumin, CRP, NLR = neutrophil-to-lymphocyte ratio, ultrasound measured thickness of rectus femoris muscle = US RF and rectus femoris + vastus intermedius = US RF + VI, handgrip strength, quality of life = EQ-5D questionnaire, and activities of daily living = Barthel's ADLs) were recorded on admission, discharge, and 1, 3, and 6 months after discharge. Results: The most significant changes were between hospital admission and discharge: US RF and RF + VI (−1.28 ± 1.97 mm, p = 0.046; −1.76 ± 2.94 mm, p = 0.05), EQ-5D score (14.6 ± 19.2, p = 0.02), and ADLs (17.1 ± 22.6; p = 0.02). There was a significant positive correlation between US RF + VI and handgrip strength (p = 0.014) and a negative correlation between weight and Barthel index (p = 0.012). There was an association between muscle function with an EQ-5D score and ADLs during outpatient check-ups, most noticeably between handgrip strength, US RF+VI, and ADLs (p = 0.08; p = 0.1, respectively). Conclusions: In patients with COVID-19 pneumonia, there is a significant reduction of health-related quality of life, impaired even 6 months after hospital discharge, influenced mainly by muscle loss. During the hospital stay, there was a significant muscle mass reduction. Ultrasound measurement of thigh muscle thickness may be a useful method to monitor muscle loss. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.